# EDGAR Filing Document

**Accession Number:** 0000932787
**File Stem:** 0000947871-26-000343
**Filing Date:** 2026-3
**Character Count:** 231222
**Document Hash:** f514bbc125983ef8f2219cb42add24ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000947871-26-000343.hdr.sgml**: 20260325

**ACCESSION NUMBER**: 0000947871-26-000343

**CONFORMED SUBMISSION TYPE**: F-3ASR

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20260325

**DATE AS OF CHANGE**: 20260325

**EFFECTIVENESS DATE**: 20260325

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STMicroelectronics N.V.
- **CENTRAL INDEX KEY:** 0000932787
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** F-3ASR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-294605
- **FILM NUMBER:** 26793503

**BUSINESS ADDRESS:**
- **STREET 1:** WTC SCHIPHOL AIRPORT
- **STREET 2:** SCHIPHOL BOULEVARD 265
- **CITY:** SCHIPHOL AIRPORT
- **STATE:** P7
- **ZIP:** 1118BH
- **BUSINESS PHONE:** 0031 20 654 3210

**MAIL ADDRESS:**
- **STREET 1:** WTC SCHIPHOL AIRPORT
- **STREET 2:** SCHIPHOL BOULEVARD 265
- **CITY:** SCHIPHOL AIRPORT
- **STATE:** P7
- **ZIP:** 1118BH

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STMICROELECTRONICS NV
- **DATE OF NAME CHANGE:** 19980626

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SGS THOMSON MICROELECTRONICS NV
- **DATE OF NAME CHANGE:** 19950310

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549**

------

**FORM F-3**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

------

**STMicroelectronics N.V.**

(Exact Name of Registrant as Specified in Its Charter)

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**The Netherlands** <br> (Jurisdiction <br> Incorporation or Organization) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Not Applicable**<br> (I.R.S. of Employer<br> Identification Number) |

---

**WTC Schiphol Airport**

**Schiphol Boulevard 265**

**1118 BH Schiphol**

**The Netherlands**

**+31-20-654-3210**

(Address and telephone number of Registrant's principal executive offices)

------

**Corporation Service Company (CSC), 80 State Street, Albany, NY, 12207**

**United States** 

**+1 302 421 6100**

(Name, address, and telephone number of agent for service)

------

**Copies to:**

**Trevor Ingram**

**Allen Overy Shearman Sterling LLP**

**One Bishops Square**

**E1 6AD, London, United Kingdom**

**+44 20 3088 0000**

------

**Approximate date of commencement of proposed sale to the public:**

**From time to time after the effective date of this registration statement.**

If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☒

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company. ☐

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;† The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

**PROSPECTUS**

**STMICROELECTRONICS N.V**

**24,755,584 ORDINARY SHARES**

**OFFERED BY**

**THE SELLING SECURITYHOLDER**

This prospectus relates to the offer and resale, from time to time, by the selling securityholder (the "Selling Securityholder") or its permitted transferees, of up to 24,755,584 ordinary shares (the "Ordinary Shares") of STMicroelectronics N.V. The Ordinary Shares that may be offered by the Selling Securityholder are those that may be acquired upon exercise of the Warrants held by the Selling Securityholder.

We are not offering or selling Ordinary Shares and will not receive any proceeds from the sale of Ordinary Shares by the Selling Securityholder pursuant to this prospectus.

Our registration of the securities covered by this prospectus does not mean that the Selling Securityholder will issue, offer or sell, as applicable, any of the securities. The Selling Securityholder may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices. We provide more information about how the Selling Securityholder may sell the securities in the section entitled *"Plan of Distribution."*

The Ordinary Shares are listed on the New York Stock Exchange (the "NYSE") under the symbol "STM". The last reported sale price of the Ordinary Shares was $31.95 per share on March 24, 2026.

**You should read this prospectus and any prospectus or amendment carefully before you invest in our securities. Investing in the Company's securities involves risks. See *"Risk Factors"* beginning on page 14 of this prospectus and any risk factors described in any applicable prospectus and in our SEC filings that are incorporated by reference in this prospectus.**

**Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.**

**PROSPECTUS DATED MARCH 25, 2026**

**[**TABLE OF CONTENTS**](#toc)**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;[PROSPECTUS](#prospectus) | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;[ABOUT THIS PROSPECTUS](#about) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;[MARKET AND INDUSTRY DATA](#market) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;[FREQUENTLY USED TERMS](#freq) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;[PROSPECTUS SUMMARY](#summ) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;[SUMMARY TERMS OF THE OFFERING](#summaryterms) | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;[CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS](#cautionary) | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;[RISK FACTORS](#risk) | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;[USE OF PROCEEDS](#use) | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;[DIVIDEND POLICY](#div) | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;[CAPITALIZATION](#capital) | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;[DESCRIPTION OF SECURITIES](#description) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;[SELLING SECURITYHOLDERS](#selling) | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;[MATERIAL DUTCH TAX CONSIDERATIONS](#material) | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;[PLAN OF DISTRIBUTION](#plan) | 31 |
| &nbsp;&nbsp;&nbsp;&nbsp;[EXPENSES RELATED TO THE OFFERING](#expenses) | 35 |
| &nbsp;&nbsp;&nbsp;&nbsp;[LEGAL MATTERS](#legal) | 36 |
| &nbsp;&nbsp;&nbsp;&nbsp;[INTERESTS OF EXPERTS AND COUNSEL](#interest) | 37 |
| &nbsp;&nbsp;&nbsp;&nbsp;[EXPERTS](#experts) | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;[ENFORCEMENT OF CIVIL LIABILITIES](#enforce) | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;[WHERE YOU CAN FIND MORE INFORMATION](#where) | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;[INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE](#incorp) | 41 |
| &nbsp;&nbsp;&nbsp;&nbsp;[PART II. INFORMATION NOT REQUIRED IN PROSPECTUS](#partii) | 42 |
| &nbsp;&nbsp;&nbsp;&nbsp;[SIGNATURES](#sig) | 47 |
| &nbsp;&nbsp;&nbsp;&nbsp;[POWER OF ATTORNEY](#poa) | 48 |
| &nbsp;&nbsp;&nbsp;&nbsp;[AUTHORIZED REPRESENTATIVE](#authorized) | 49 |

---

**ABOUT THIS PROSPECTUS**

You should rely only on the information contained in this prospectus, any amendment or supplement to this prospectus, including information incorporated by reference herein or therein, or any free writing prospectus prepared by or on our behalf. Any amendment or supplement may also add, update or change information included in this prospectus. Any statement contained in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in such amendment or supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. See *"Where You Can Find More Information"* and *"Incorporation of Certain Documents By Reference."*

Neither we nor the Selling Securityholder have authorized any other person to provide you with different or additional information. Neither we nor the Selling Securityholder take responsibility for, nor can we provide assurance as to the reliability of, any other information that others may provide. The information contained in this prospectus, any applicable prospectus or any document incorporated by reference in this prospectus is accurate only as of their respective dates or as of the dates stated therein, regardless of the time of delivery of this prospectus, any applicable prospectus or the documents incorporated by reference in this prospectus, and our business, financial condition, results of operations and/or prospects may have changed since those dates. This prospectus contains summaries of certain provisions contained in some of the documents described in this prospectus, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to in this prospectus have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described under *"Where You Can Find More Information."*

This prospectus does not constitute an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. Except as otherwise set forth in this prospectus, neither we nor the Selling Securityholder have taken any action to permit a public offering of these securities outside the United States or to permit the possession or distribution of this prospectus outside the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions relating to the offering of these securities and the distribution of this prospectus outside the United States.

**MARKET AND INDUSTRY DATA**

Any third-party information included in this prospectus or any document incorporated by reference in this prospectus has been accurately reproduced and, as far as STM is aware and is able to ascertain from the information published by such third parties, the reproduced information is accurate and no facts have been omitted which would render such information inaccurate or misleading. While STM believes such information is reliable, it has not independently verified any third-party information.

**FREQUENTLY USED TERMS**

*Unless otherwise stated or unless the context otherwise requires, references to "We," "Our," "Us,"* the "*Company*" or "*STM*" generally refer to STMicroelectronics N.V. and its consolidated subsidiaries.

In this document:

"*AGM*" means the annual general meeting of shareholders of STM.

"*Articles*" means the articles of association of STM, as amended from time to time.

"*Code*" means the United States Internal Revenue Code of 1986, as amended.

"*Dutch Law*" means the provisions of the laws of The Netherlands.

"*Exchange Act*" means the United States Securities Exchange Act of 1934, as amended.

"*IRS*" means the U.S. Internal Revenue Service.

"*Managing Board*" means the managing board of the Company.

"*NYSE*" means the New York Stock Exchange.

"*Ordinary Shares*" means ordinary shares of STM, with a nominal value of €0.0 l per share.

"*PFIC*" means a passive foreign investment company.

"*SEC*" means the United States Securities and Exchange Commission.

"*Securities Act*" means the United States Securities Act of 1933, as amended.

"*Supervisory Board*" means the supervisory board of the Company.

"*Warrant*" means a warrant of the Company, exercisable for one Ordinary Share at an exercise price of $28.38 per share, subject to adjustments as described in the Warrant Agreement as set forth under "*Description of Securities*" in this registration statement.

"*Warrant Agreement*" means the warrant agreement, dated as of February 6, 2026, by and between the Company and Amazon.com NV Investment Holdings LLC (the "Warrantholder") as warrantholder, filed with the SEC on February 26, 2026 as Exhibit 4.1. to our 2025 Form 20-F.

"*Warrant Shares*" means the Ordinary Shares to be issued from time to time pursuant to the Warrant Agreement.

"*2025 Form 20-F*" means our annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the SEC on February 26, 2026.

**PROSPECTUS SUMMARY**

This summary highlights selected information contained elsewhere in this prospectus or incorporated by reference in this prospectus. This summary does not contain all of the information you should consider before investing in the Company's securities. Before making an investment decision, you should read this entire prospectus carefully, especially the section entitled "*Risk Factors*", the financial statements and related notes thereto, the documents incorporated by reference in this prospectus and the other documents to which this prospectus refers. Some of the statements in this prospectus constitute forward-looking statements that involve risks and uncertainties. See "*Cautionary Note Regarding Forward-Looking Statements*" for more information. See also the section entitled "*Where You Can Find More Information*."

**STMicroelectronics N.V.**

***Overview***

We are a global semiconductor company that designs, develops, manufactures and markets a broad range of products used in a wide variety of applications for the four end-markets we address: automotive, industrial, personal electronics and communications equipment, computers and peripherals.

Our diverse product portfolio includes discrete and general-purpose components, application-specific integrated circuits, full-custom devices and semi-custom devices and application-specific standard products for analog, digital and mixed-signal applications, benefitting from a unique, strong foundation of proprietary and differentiated leading-edge technologies.

***Corporate Information***

The Company, incorporated under the laws of The Netherlands on May 21, 1987, as a public limited liability company *(naamloze vennootschap)* with its registered office at WTC Schiphol Airport, Schiphol Boulevard 265, 1118 BH Schiphol, The Netherlands, is registered with the trade register (*handelsregister*) of the Dutch Chamber of Commerce (*Kamer van Koophandel*) under registration number 33194537.

The mailing address of the Company's principal executive office is WTC Schiphol Airport, Schiphol Boulevard 265, 1118 BH Schiphol, The Netherlands and its telephone number is +31-20-654-3210. The Company's agent for service in the United States is: Corporation Service Company (CSC), 80 State Street, Albany, New York, 12207 (telephone number: +1 302 421 6100).

The Company's principal website address is https://www.st.com. This website and the information contained therein or connected thereto shall not be deemed to be incorporated into this prospectus.

***Implications of Being a "Foreign Private Issuer"***

The Company reports under the Exchange Act as a non-U.S. company with foreign private issuer status. As long as we continue to qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the sections of the Exchange Act imposing liability for insiders who profit from trades made in a short period of time; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the rules under the Exchange Act requiring the filing of quarterly reports with the SEC on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events.

In addition, we are not required to file annual reports and financial statements with the SEC as promptly as U.S. domestic companies whose securities are registered under the Exchange Act, and are not required to comply with Regulation FD, which restricts the selective disclosure of material information.

Further, we are exempt from certain corporate governance requirements of NYSE by virtue of being a foreign private issuer. As a foreign private issuer, we are permitted to follow the corporate governance practices of our home country in lieu of certain provisions of the NYSE Standards.

**SUMMARY TERMS OF THE OFFERING**

*The summary below describes the principal terms of the offering. The "Description of Securities" section of this prospectus contains a more detailed description of the Company's Ordinary Shares.*

We are registering the offer and resale, from time to time, by the Selling Securityholder or its permitted transferees, of up to 24,755,584 Ordinary Shares of STMicroelectronics N.V.

Any investment in the securities offered hereby involves a high degree of risk. You should carefully consider the information set forth under *"Risk Factors"* on page 14 of this prospectus.

---

| | |
|:---|:---|
| Ordinary Shares Offered by the Selling Securityholder | Up to 24,755,584 |
| Offering price may be issued upon | The Ordinary Shares offered by the Selling Securityholder under this prospectus may be offered and sold at prevailing market prices, privately negotiated prices or such other prices as the Selling Securityholder may determine. See the section entitled "*Plan of Distribution*." |
| Use of Proceeds | We will not receive any proceeds from the sale of the Ordinary Shares to be offered by the Selling Securityholder. |
| Dividend policy | We have paid, and intend to continue to pay, an interim dividend on our Ordinary Shares on a quarterly basis in 2026; however, decisions in relation to our dividend policy are determined by our Board. See "*Dividend Policy*." |
| Market for our securities | Our Ordinary Shares are listed on the NYSE under the symbol "STM". |
| Risk factors | Investing in our securities involves a high degree of risk. See "*Risk Factors*" for a description of certain of the risks you should consider before investing in the Company. |

---

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

This prospectus and the documents incorporated herein by reference include statements that are, or may be deemed to be, "forward-looking statements" within the meaning of the U.S. federal securities laws, including statements under the heading *"Ri sk Factors,"* statements of future expectations and other forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology such as "aim," "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "opportunity," "plan," "potential," "predict," "projected," "should," "strategy," "suggests," "targets," "will," "will be" or "would" or similar expressions or the negatives thereof, or other variations thereof, or comparable terminology, or by discussions of strategy, plans or intentions. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this prospectus and include statements regarding the intentions, beliefs or current expectations of management concerning, among other things, results of operations, financial condition, liquidity, prospects, growth, strategies and the industry in which we operate.

You are cautioned that forward-looking statements are not guarantees of future performance and that actual results of operations, financial condition and liquidity, and the development of the industry in which the Company operates, may differ materially from those made in or suggested by the forward-looking statements contained in this prospectus. In addition, even if our results of operations, financial condition and liquidity, and the development of the industry in which we operate are consistent with the forward- looking statements contained in this prospectus, those results or developments may not be indicative of results or developments in subsequent periods.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance and actual financial condition, results of operations and cash flows. The development of the industry in which the Company operates may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this prospectus.

These statements are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those anticipated by such statements. You should not place undue reliance on these forward-looking statements. As a result of the number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Factors that could cause such differences in actual results include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in global trade policies, including the adoption and expansion of tariffs and trade barriers, that could affect the macro-economic environment and adversely impact the demand for our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• uncertain macro-economic and industry trends (such as inflation and fluctuations in supply chains), which may impact production capacity and end-market demand for our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• customer demand that differs from projections which may require us to undertake transformation measures that may not be successful in realizing the expected benefits in full or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability to design, manufacture and sell innovative products in a rapidly changing technological environment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in economic, social, public health, labor, political, or infrastructure conditions in the locations where we, our customers, or our suppliers operate, including as a result of macro-economic or regional events, geopolitical and military conflicts, social unrest, labor actions, or terrorist activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unanticipated events or circumstances, which may impact our ability to execute our plans and/or meet the objectives of our research and development and manufacturing programs, which benefit from public funding;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• financial difficulties with any of our major distributors or significant curtailment of purchases by key customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the loading, product mix, and manufacturing performance of our production facilities and/or our required volume to fulfill capacity reserved with suppliers or third-party manufacturing providers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• availability and costs of equipment, raw materials, utilities, third-party manufacturing services and technology, or other supplies required by our operations (including increasing costs resulting from inflation);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the functionalities and performance of our IT systems, which are subject to cybersecurity threats and which support our critical operational activities including manufacturing, finance and sales, and any breaches of our IT systems or those of our customers, suppliers, partners and providers of third-party licensed technology;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• theft, loss, or misuse of personal data about our employees, customers, or other third parties, and breaches of data privacy legislation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of intellectual property claims by our competitors or other third parties, and our ability to obtain required licenses on reasonable terms and conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in our overall tax position as a result of changes in tax rules, new or revised legislation, the outcome of tax audits or changes in international tax treaties which may impact our results of operations as well as our ability to accurately estimate tax credits, benefits, deductions and provisions and to realize deferred tax assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• variations in the foreign exchange markets and, more particularly, the U.S. dollar exchange rate as compared to the Euro and the other major currencies we use for our operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the outcome of ongoing litigation as well as the impact of any new litigation to which we may become a defendant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• product liability or warranty claims, claims based on epidemic or delivery failure, or other claims relating to our products, or recalls by our customers for products containing our parts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• natural events such as severe weather, earthquakes, tsunamis, volcano eruptions or other acts of nature, the effects of climate change, health risks and epidemics or pandemics in locations where we, our customers or our suppliers operate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increased regulation and initiatives in our industry, including those concerning climate change and sustainability matters and our goal to become carbon neutral in all direct and indirect emissions (scopes 1 and 2), product transportation, business travel, and employee commuting emissions (our scope 3 focus), and to achieve our 100% renewable electricity sourcing goal by the end of 2027;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• epidemics or pandemics, which may negatively impact the global economy in a significant manner for an extended period of time, and could also materially adversely affect our business and operating results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• industry changes resulting from vertical and horizontal consolidation among our suppliers, competitors, and customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability to successfully ramp up new programs that could be impacted by factors beyond our control, including the availability of critical third-party components and performance of subcontractors in line with our expectations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• individual customer use of certain products, which may differ from the anticipated uses of such products and result in differences in performance, including energy consumption, may lead to a failure to achieve our disclosed emission-reduction goals, adverse legal action or additional research costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other risks and uncertainties described or incorporated by reference in this prospectus, including those under "*Risk Factors*."

The Company undertakes no obligation to update publicly or release any revisions to these forward-looking statements to reflect events or circumstances or to reflect the occurrence of unanticipated events, other than as required by law.

The foregoing factors and others described under the section entitled *"Risk Factors",* as well as in the 2025 Form 20-F and in other documents that we may file with the SEC should not be construed as exhaustive. There are other factors that may cause our actual results to differ materially from the forward-looking statements contained in this prospectus. Moreover, new risks emerge from time to time and it is not possible for us to predict all such risks. We cannot assess the impact of all risks on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, you should not place undue reliance on forward-looking statements as a prediction of actual results. The Company urges you to read the section of this prospectus entitled *"Risk Factors",* as well as the documents incorporated by reference herein and any prospectus for a more complete discussion of the factors that could affect its future performance and the industry in which it operates.

The forward-looking statements are based on plans, estimates and projections as they are currently available to the management of STM, and we do not undertake any obligation nor expect to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to the Company or to persons acting on behalf of the Company are expressly qualified in their entirety by the cautionary statements referred to above and contained elsewhere in this prospectus or incorporated by reference herein.

**RISK FACTORS**

An investment in the Company's securities carries a significant degree of risk. Before you decide to purchase the Company's securities, you should carefully consider all risk factors set forth in any applicable prospectus and the documents incorporated by reference in this prospectus, including the factors discussed under the heading "*Risk Factors*" in our most recent annual report on Form 20-F or any updates in our current reports on Form 6-K, which may be amended, supplemented or superseded from time to time by the other reports we file with the SEC in the future or by information in the applicable prospectus. See *"Incorporation of Certain Documents by Reference."* The risks and uncertainties we have described are not the only risks we face. Additional risks and uncertainties of which we are not presently aware or that we currently deem immaterial could also affect our business operations and financial condition. If any of these risks actually occur, our business, financial condition, results of operations or prospects could be materially affected. As a result, the trading price of the Company's securities could decline and you could lose part or all of your investment.

**USE OF PROCEEDS**

All of the Ordinary Shares offered by the Selling Securityholder pursuant to this prospectus will be sold by the Selling Securityholder. We will not receive any of the proceeds from these sales.

**DIVIDEND POLICY**

The AGM approved an interim dividend of $0.36 per Ordinary Share on May 28, 2025, to be distributed in quarterly installments of $0.09 in each of the second, third and fourth quarters of 2025 and the first quarter of 2026 to shareholders of record in the month of each quarterly payment. An amount of $81 million corresponding to the first installment, $80 million corresponding to the second installment and $71 million corresponding to the third installment were paid as of December 31, 2025.

We intend to continue to pay an interim dividend on our Ordinary Shares on a quarterly basis; however, decisions in relation to our dividend policy are ultimately determined by our Board.

**CAPITALIZATION**

The following table sets forth our capitalization as of December 31, 2025.

The information in this table should be read in conjunction with the audited annual consolidated financial statements of STM as of December 31, 2025 and 2024 and for each of the three years in the period ended December 31, 2025, including the related notes thereto, included in the 2025 Form 20-F incorporated by reference into this prospectus.

Historical results are not necessarily indicative of results to be expected in any future period.

---

| | |
|:---|:---|
|  | &nbsp;&nbsp; **As of December 31, 2025**<br> ***(in $ million)*** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Debt Outstanding:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior Unsecured Convertible Bonds (at nominal amount) | &nbsp;&nbsp; 750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other long-term debt | &nbsp;&nbsp;1086 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term debt | &nbsp;&nbsp;298 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Equity:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, par value €1.04 per share | &nbsp;&nbsp;1157 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | &nbsp;&nbsp;3281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | &nbsp;&nbsp;13082 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock | &nbsp;&nbsp;(637) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | &nbsp;&nbsp;945 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total shareholders' equity** | &nbsp;&nbsp;**17828** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Capitalization** | &nbsp;&nbsp;**19962** |

---

**DESCRIPTION OF SECURITIES**

*The following description of our share capital summarizes certain provisions of the Articles. Such summaries do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of our Articles.*

**General**

STM is a public limited liability company *(naamloze vennootschap)* incorporated and existing under the laws of The Netherlands, having its registered office at WTC Schiphol Airport, Schiphol Boulevard 265, 1118 BH Schiphol, The Netherlands, and registered with the trade register (*handelsregister*) of the Dutch Chamber of Commerce (*Kamer van Koophandel*) under registration number 33194537.

The corporate objects of the Company are set out in the Articles. They are to be interpreted in the broadest sense and any transaction or agreement which is entered into by the Company that is not inconsistent with the specified objects will be deemed to be within the scope of such objects.

**Shares**

**Share Capital**

STM's current issued share capital equals €947,733,196.80, consisting of 911,281,920 Ordinary Shares, each with a nominal value of €1.04. All issued Ordinary Shares are fully paid and subscribed for.

The authorized capital of STM (including the issued share capital) is set at €1,809,600,000, consisting of 1,200,000,000 Ordinary Shares and 540,000,000 preference shares.

**Share Issuances**

Our shareholders' meeting, upon proposal and on the terms and conditions set by our Supervisory Board, has the power to issue shares and rights to subscribe for shares. The shareholders' meeting may authorize our Supervisory Board, for a period of no more than five years, to issue shares and rights to subscribe for shares and to determine the terms and conditions of such issuances.

Our shares may not be issued at less than their par value. Our Ordinary Shares must be fully paid up at the time of their issuance. Our preference shares must be paid up for at least 25% of their par value at the time of their issuance (and the remaining 75% if and when requested by our Managing Board).

Our authorized share capital is not restricted by redemption provisions, sinking fund provisions or liability to further capital calls by us and our Articles allows for the acquisition of own shares and the cancellation of shares.

Type II shares are Ordinary Shares in the form of an entry in our shareholders register with the issue of a share certificate consisting of a main part without a dividend coupon. In addition to type II shares, type I shares are available. Type I shares are Ordinary Shares in the form of an entry in our shareholders register without the issue of a share certificate. Type II shares are only available should our Supervisory Board decide to offer them. Our preference shares are in the form of an entry in our shareholders register without issue of a share certificate.

Non-issued authorized share capital, which is different from issued share capital, allows us to proceed with capital increases excluding the preemptive rights, upon our Supervisory Board's decision. Other securities in circulation which give access to our share capital include (i) the options giving the right to subscribe to our shares granted to our employees, including the members of our Managing Board and our senior management; (ii) the options giving the right to subscribe to our shares granted in the past to the members of our Supervisory Board, its secretaries and controllers, as described in "Item 6. Directors, Senior Management and Employees" in our 2025 Form 20-F; (iii) our bonds; and (iv) the option giving the right to subscribe to our preference shares to *Stichting Continuïteit ST*. We do not have securities not representing our share capital.

**Preemptive Rights**

Each holder of Ordinary Shares has a pro rata preemptive right to subscribe to an offering of Ordinary Shares issued for cash in proportion to the number of Ordinary Shares which he owns. There is no preemptive right with respect to an offering of shares for non-cash consideration, with respect to an offering of shares to our employees or to the employees of one of our subsidiaries, or with respect to preference shares.

Our shareholders' meeting, upon proposal by our Supervisory Board, has the power to limit or exclude preemptive rights in connection with new issuances of shares. Such a resolution of the shareholders' meeting must be taken with a majority of at least two-thirds of the votes cast if at such shareholders' meeting less than 50% of the issued and outstanding share capital is present or represented. Otherwise, such a resolution can be taken by a simple majority of the votes cast at a shareholders' meeting at which at least 15% of our issued and outstanding share capital is present or represented. Our shareholders' meeting may authorize our Supervisory Board, for a period of no more than five years, to limit or exclude preemptive rights.

**Acquisition of Ordinary Shares in Our Own Share Capital**

We may acquire our own shares, subject to certain provisions of Dutch law and of our Articles. Share acquisitions may be effected by our Managing Board, subject to the approval of our Supervisory Board, only if the shareholders' meeting has authorized our Managing Board to effect such repurchases, which authorization may apply for a maximum period of 18 months. We may not vote shares we hold in treasury. Our purchases of our own shares are subject to acquisition price conditions as authorized by our shareholders' meeting. Our Articles provide that we shall be able to acquire shares in our own share capital in order to transfer these shares under employee stock option or stock purchase plans, without an authorization of our shareholders' meeting.

Upon the proposal of our Supervisory Board, our shareholders' meeting may, in accordance with the legal provisions, reduce our issued capital by canceling the shares that we hold in treasury, by reducing the par value of the shares or by canceling our preference shares.

**Voting Rights**

There are currently no limitations imposed by Dutch law or by our Articles on the right of non-resident holders to hold or vote the shares. Each share is entitled to one vote.

The 540,000,000 preference shares, when issued, will entitle a holder to full voting rights and to a preferential right to dividends and distributions upon liquidation.

Unless otherwise required by our Articles or Dutch law, resolutions of shareholders' meetings require the approval of a simple majority of the votes cast at a meeting at which at least 15% of the issued and outstanding share capital is present or represented, subject to the provisions explained below. We may not vote our Ordinary Shares held in treasury. Blank and invalid votes shall not be counted.

A quorum of shareholders, present or represented, holding at least 50% of our issued share capital, is required to dismiss a member of our Managing Board, unless the dismissal is proposed by our Supervisory Board. In the event of the lack of a quorum, a second shareholders' meeting must be held within four weeks, with no applicable quorum requirement. Any decision or authorization by the shareholders' meeting which has or could have the effect of excluding or limiting preferential subscription rights must be taken by a majority of at least two-thirds of the votes cast, if at the shareholders' meeting less than 50% of the issued and outstanding share capital is present or represented. Otherwise such a resolution can be taken by a simple majority at a meeting at which at least 15% of the issued and outstanding share capital is represented.

**Amendment of the Articles and Liquidation**

Our Articles may only be amended (and our liquidation can only be decided on) if amendments are proposed by our Supervisory Board and approved by a simple majority of the votes cast at a shareholders' meeting at which at least 15% of the issued and outstanding share capital is present or represented. The complete proposal for the amendment (or liquidation) must be made available for inspection by the shareholders and the other persons entitled to attend shareholders' meetings at our offices as from the day of the notice convening such meeting until the end of the meeting. Any amendment of our Articles that negatively affects the rights of the holders of a certain class of shares requires the prior approval of the meeting of holders of such class of shares.

**Annual Shareholders Meetings**

Our ordinary shareholders' meetings are held at least annually, within six months after the close of each financial year, in The Netherlands. Extraordinary shareholders' meetings may be held as often as our Supervisory Board deems necessary, and must be held upon the written request of registered shareholders or other persons entitled to attend shareholders' meetings of at least 10% of the total issued share capital to our Managing Board or our Supervisory Board specifying in detail the business to be dealt with. Such written requests may not be submitted electronically.

All shareholders and other persons entitled to attend shareholders' meetings may attend in person or be represented by a person holding a written proxy. Shareholders and other persons entitled to vote, may do so pursuant to our Articles. Subject to the approval of our Supervisory Board, our Managing Board may resolve to facilitate the use of electronic means of communication in relation to the participation and voting in shareholders' meetings. Dutch law prescribes a fixed registration date of 28 days prior to the shareholders' meeting, which means that shareholders and other persons entitled to attend shareholders' meetings are those persons who have such rights at the 28th day prior to the shareholders' meeting and, as such, are registered in a register designated by our Managing Board, regardless of who is a shareholder or otherwise a person entitled to attend shareholders' meetings at the time of the meeting if a registration date would not be applicable. In the notice convening the shareholders' meeting, the time of registration must be mentioned as well as the manner in which shareholders and other persons entitled to attend shareholders' meetings can register themselves and the manner in which they can exercise their rights.

All matters regarding admittance to the shareholders' meeting, the exercise of voting rights and the result of voting, as well as any other matters regarding the business of the shareholders' meeting, shall be decided upon by the chairman of that meeting, in accordance with the requirements of Section 2:13 of the Dutch Civil Code.

Our Articles allow for separate meetings for holders of Ordinary Shares and for holders of preference shares. At a meeting of holders of preference shares at which the entire issued capital of shares of such class is represented, valid resolutions may be adopted even if the requirements in respect of the place of the meeting and the giving of notice have not been observed, provided that such resolutions are adopted by unanimous vote. Also, valid resolutions of preference shareholder meetings may be adopted outside a meeting if all persons entitled to vote on our preference shares indicate in writing that they vote in favor of the proposed resolution, provided that no depositary receipts for preference shares have been issued with our cooperation.

**Distributions on Winding up of the Company**

In the event of our dissolution and liquidation, after payment of all debts and liquidation expenses, the holders of preference shares if issued, would receive the paid up portion of the par value of their preference shares. Any assets then remaining shall be distributed among the holders of Ordinary Shares in proportion to the par value of their shareholdings.

**Interested Directors**

The Company's supervisory board charter and management board charter contain specific provisions regarding interested directors and set forth procedures for approval of contracts or transactions involving an interested director. If a director has a direct or indirect financial interest conflicting with that of the Company in any contract or transaction to which the Company will be party, such interested director shall advise the Supervisory thereof, cause a record of his or her statement to be included in the minutes of the meeting, and may not take part in relevant deliberations.

**Warrants**

On February 6, 2026, the Company entered into the Warrant Agreement with the Warrantholder to issue to the Warrantholder a Warrant to acquire up to 24,755,584 of the Company's Ordinary Shares at an exercise price of $28.38 per share, and on the terms and conditions set forth in the Warrant.

Upon issuance of the Warrant, 562,627 of the Warrant Shares vested, and on the 6<sup>th</sup> month anniversary of the execution date of the Warrant, a further 562,627 of the Warrant Shares will vest. The remainder of the Warrant Shares are subject to vesting over time based on payments made by Warrantholder or on the Warrantholder's behalf under the current and any possible future commercial agreement with the Company.

The Warrant allows for cashless exercise at the Warrantholder's discretion and expires at 5:00 p.m., Seattle time, on February 7, 2033. The exercise price and the number of Ordinary Shares are subject to customary anti-dilution adjustments. Under the Transaction Agreement, the Company has granted customary registration rights for the Warrant Shares and has agreed to give Amazon advance notice of certain acquisition transactions involving the Company.

The foregoing description of the Warrant is qualified in its entirety by reference to the full text of the Warrant Agreement.

**Dividends**

The Company is governed under the laws of The Netherlands. The Articles provide that the net result for the year, after deduction of (i) any amount to set up and maintain reserves required by Dutch Law and the Articles, (ii) if any of the Company's preference shares are issued and outstanding, the dividend to be paid to the holders of preference shares and (iii) the aforementioned allocation to the reserve fund, is subject to the disposition by the AGM.

Subject to certain exceptions, dividends may only be paid out of the profits as shown in our adopted annual accounts. Our profits must first be used to set up and maintain reserves required by Dutch law and our Articles. Subsequently, if any of our preference shares are issued and outstanding, preference shareholders shall be paid a dividend, which will be a percentage of the paid up part of the par value of their preference shares. Our Supervisory Board may then, upon proposal of our Managing Board, also establish reserves out of our annual profits. The portion of our annual profits that remains after the establishment or maintenance of reserves and the payment of a dividend to our preference shareholders is at the disposal of our shareholders' meeting. No distribution may be made to our shareholders when the equity after such distribution is or becomes inferior to the fully-paid share capital, increased by the legal reserves. Our preference shares are cumulative by nature, which means that if in a financial year the dividend on the preference shares cannot be (fully) paid, the deficit must first be paid in the following financial year(s).

Our Supervisory Board independently as well as our shareholders' meeting, upon the proposal of our Supervisory Board, may each declare distributions out of our share premium reserve and other reserves available for shareholder distributions under Dutch law. Pursuant to a resolution of our Supervisory Board, distributions adopted by the shareholders' meeting may be fully or partially made in the form of our new shares to be issued. Our Supervisory Board may, subject to certain statutory provisions, make one or more interim distributions in respect of any year before the accounts for such year have been adopted at a shareholders' meeting. Rights to cash dividends and distributions that have not been collected within five years after the date on which they became due and payable shall revert to us.

The AGM held on May 28, 2025, authorized the distribution of a cash dividend of $0.36 per outstanding share of the Company's common stock, to be distributed in quarterly installments of $0.09 in each of the second, third and fourth quarters of 2025 and first quarter of 2026. An amount of $81 million corresponding to the first installment, $80 million corresponding to the second installment and $71 million corresponding to the third installment were paid as of December 31, 2025.

**Preference Shares**

The authorized capital of STM (including the issued share capital) is set at €1,809,600,000, consisting of 1,200,000,000 Ordinary Shares and 540,000,000 preference shares, each with a nominal value of €1.04.

The 540,000,000 preference shares, when issued, will entitle a holder to full voting rights and to a preferential right to dividends and distributions upon liquidation.

The Company is a party to an option agreement regarding the preference shares with Stichting Continuïteit ST (the "*Stichting*"), entered into on January 22, 2007, with a duration of ten years, an agreement which was extended for additional ten years in October 2016. The Managing Board and Supervisory Board, along with the board of the Stichting, have declared that they are jointly of the opinion that the Stichting is independent of the Company. The option agreement provides for the issuance of up to a maximum 540,000,000 preference shares. Any such shares would be issued to the Stichting upon its request and in its sole discretion and upon payment of at least 25% of the par value of the preference shares to be issued. The shares would be issuable in the event of actions which the board of the Stichting determines would be contrary to the Company's interests, shareholders and other stakeholders and which, in the event of a creeping acquisition or offer for the Company's Ordinary Shares, are not supported by the Company's Managing Board and Supervisory Board. The preference shares may remain outstanding for no longer than two years. The effect of the preference shares may be to deter potential acquirers from effecting an unsolicited acquisition resulting in a change of control as well as to create a level-playing field in the event actions which are considered to be hostile by the Company's Managing Board and Supervisory Board, as described above, occur and which the board of the Stichting determines to be contrary to the Company's interests, shareholders and other stakeholders.

There were no preference shares issued as of December 31, 2025 and December 31, 2024.

**U.S. Transfer Agent**

The U.S. transfer agent for the Ordinary Shares is J.P. Morgan.

**SELLING SECURITYHOLDERS**

This prospectus relates to the resale by the Selling Securityholder from time to time of up to 24,755,584 Ordinary Shares underlying a warrant to purchase the Company's Ordinary Shares.

On February 6, 2026, the Company and Amazon.com, Inc. ("Amazon") entered into a transaction agreement (the "Transaction Agreement"), under which the Company issued to the Selling Securityholder, a wholly-owned subsidiary of Amazon, a warrant to purchase up to an aggregate of 24,755,584 ordinary shares at an exercise price of $28.38 per share. The Warrant allows for cashless exercise and expires at 5:00 p.m., Seattle time, on February 7, 2033. Upon issuance of the Warrant, 562,627 of the Warrant Shares vested, and on the 6<sup>th</sup> month anniversary of the execution date of the Warrant, a further 562,627 of the Warrant Shares will vest, after which date the right to purchase ordinary shares upon exercise of the Warrant is subject to vesting based on qualifying payments (as defined in the Warrant) for the purchase of all products and services by or on behalf of Amazon and its affiliates over the term of the Warrant.

The exercise price and the number of Ordinary Shares subject to the Warrant are subject to customary anti-dilution adjustments. Upon the consummation of an acquisition transaction (as defined in the Transaction Agreement), subject to a specified condition, the unvested portion of the Warrant will vest in full. So long as the Warrant is unexercised, the Warrant does not entitle the Selling Securityholder to any voting rights or any other shareholder rights. The Transaction Agreement includes customary registration rights, representations and warranties and covenants of the Company and Amazon, and certain restrictions on the Selling Securityholder's ability to transfer the Warrant and the Ordinary Shares issuable upon exercise of the Warrant.

Pursuant to the Transaction Agreement, we agreed to file a registration statement with the SEC, providing for the offer and sale, from time to time, of the Ordinary Shares issuable upon exercise of the Warrant. We have agreed with the Selling Securityholder to use commercially reasonable efforts to cause the registration statement of which this prospectus constitutes a part to remain continuously effective, and to replace such registration statement at or before its expiration with a successor registration statement, until the date on which all of the Ordinary Shares included in this prospectus have been sold in accordance with the plan and method of distribution described herein. See "*Plan of Distribution*."

The table below sets forth, as of the date of this prospectus, the name of the Selling Securityholder for which we are registering Ordinary Shares for resale to the public, the aggregate number of Ordinary Shares beneficially owned and the aggregate principal amount that the Selling Securityholder may offer pursuant to this prospectus. The individuals and entities listed below have beneficial ownership over their respective securities. The SEC has defined "beneficial ownership" of a security to mean the possession, directly or indirectly, of voting power and/or investment power over such security. A shareholder is also deemed to be, as of any date, the beneficial owner of all securities that such shareholder has the right to acquire within 60 days after that date through (i) the exercise of any option, warrant or right, (ii) the conversion of a security, (iii) the power to revoke a trust, discretionary account or similar arrangement, or (iv) the automatic termination of a trust, discretionary account or similar arrangement. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares subject to options or other rights (as set forth above) held by that person that are currently exercisable, or will become exercisable within 60 days thereafter, are deemed outstanding, while such shares are not deemed outstanding for purposes of computing percentage ownership of any other person. Unless otherwise indicated below, to our knowledge, the entity named in the table has sole voting and sole investment power with respect to all securities that it beneficially owns, subject to community property laws where applicable.

We cannot advise you as to whether the Selling Securityholder will in fact exercise the Warrant and subsequently offer and sell any or all of such Ordinary Shares. As such, we are unable to declare the number of Ordinary Shares that the Selling Securityholder will retain after any such sale. In addition, the Selling Securityholder may sell, transfer or otherwise dispose of, at any time and from time to time, the Ordinary Shares in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus.

Selling Securityholder information for each additional Selling Securityholder, if any, will be set forth by prospectus to the extent required prior to the time of any offer or sale of such Selling Securityholder's Ordinary Shares pursuant to this prospectus. Any prospectus may add, update, substitute, or change the information contained in this prospectus, including the identity of each Selling Securityholder and the number of Ordinary Shares registered on its behalf. A Selling Securityholder may sell or otherwise transfer all, some or none of such Ordinary Shares in this offering. See "*Plan of Distribution*."

**Ordinary Shares**

---

| | | | |
|:---|:---|:---|:---|
|  | **Securities**<br> **Beneficially Owned prior to**<br> **This Offering <sup>(1)</sup>** | **Number of<br> Ordinary Shares**<br> **Offered<sup>(2)</sup>** | **Securities**<br> **Beneficially<br> Owned after**<br> **This Offering** |
| **Name of Selling Securityholder** |  |  |  |
| Amazon.com NV Investment Holdings LLC<sup>(3)</sup> | 562627 | 24755584 | 562627 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Represents 562,627 Ordinary Shares underlying the Warrant that have vested up until March 25, 2026. On the 6th month anniversary of the execution date of the Warrant, a further 562,627 of the Warrant Shares will
vest, and the remainder of the Warrant Shares are subject to vesting in multiple traches over the term of the Warrant based on payments
to us from or on behalf of Amazon or its affiliates under a commercial agreement or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The number of Ordinary Shares that may be offered by the Selling Securityholder
is the maximum number of Ordinary Shares issuable to the Selling Securityholder upon exercise of the Warrant ,
assuming full vesting of the Warrant .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) The Selling Securityholder is a wholly-owned subsidiary of Amazon. Amazon
has sole voting and investment power with respect to any Ordinary Shares held by the Selling Securityholder. The address of Amazon.com
NV Investment Holdings LLC is c/o Amazon.com, Inc., 410 Terry Avenue North, Seattle, Washington 98109.

**MATERIAL DUTCH TAX CONSIDERATIONS**

**Scope of Discussion**

This section only outlines certain material Dutch tax consequences of the acquisition, holding and disposal of Ordinary Shares. This section does not purport to describe all possible tax considerations or consequences that may be relevant to a holder or prospective holder of Ordinary Shares and does not purport to deal with the tax consequences applicable to all categories of investors, some of which (such as trusts or similar arrangements) may be subject to special rules. In view of its general nature, this section should be treated with corresponding caution.

This section is based on the tax laws of The Netherlands, published regulations thereunder and published authoritative case law, all as in effect on the date hereof, including, for the avoidance of doubt, the tax rates, tax brackets and deemed returns applicable on the date hereof, and all of which are subject to change, possibly with retroactive effect. Any such change may invalidate the contents of this section, which will not be updated to reflect such change. Where this section refers to "The Netherlands" or "Dutch" it refers only to the part of the Kingdom of The Netherlands located in Europe.

This section is intended as general information only and is not Dutch tax advice or a complete description of all Dutch tax consequences relating to the acquisition, holding and disposal of the Ordinary Shares. Holders or prospective holders of Ordinary Shares should consult their own tax advisor regarding the Dutch tax consequences relating to the acquisition, holding and disposal of Ordinary Shares in light of their particular circumstances.

This section does not describe any Dutch tax considerations or consequences arising from the Dutch Minimum Tax Act 2024 (*Wet minimumbelasting 2024*; the Dutch implementation of Directive (EU) 2022/2523 of 14 December 2022 on ensuring a global minimum level of taxation for multinational enterprise groups and large-scale domestic groups in the European Union) which may be relevant for a particular holder.

Please note that this section does not describe the Dutch tax consequences for:

&nbsp;&nbsp;&nbsp;&nbsp;(i) a holder of Ordinary Shares if such holder has a substantial interest (*aanmerkelijk belang*) or
deemed substantial interest (*fictief aanmerkelijk belang*) in STM under the Dutch Income Tax Act 2001 (*Wet inkomstenbelasting 2001*). Generally, a holder is considered to hold a substantial interest in STM, if such holder alone or, in the case of an individual,
together with such holder's partner for Dutch income tax purposes, or any relatives by blood or marriage in the direct line (including
foster children), directly or indirectly, holds (i) an interest of 5% or more of the total issued and outstanding capital of STM or of
5% or more of the issued and outstanding capital of a certain class of shares; or (ii) rights to acquire, directly or indirectly, such
interest; or (iii) certain profit sharing rights that relate to 5% or more of STM's annual profits or to 5% or more of STM's
liquidation proceeds. A deemed substantial interest may arise if a substantial interest (or part thereof) in STM has been disposed of,
or is deemed to have been disposed of, on a non-recognition basis;

&nbsp;&nbsp;&nbsp;&nbsp;(ii) a holder of Ordinary Shares if the Ordinary Shares held by such holder qualify or qualified as a participation
(*deelneming*) for purposes of the Dutch Corporate Income Tax Act 1969 (*Wet op de vennootschapsbelasting 1969*). Generally,
a holder's shareholding, or right to acquire, of 5% or more in STM's nominal paid-up share capital qualifies as a participation.
A holder may also have a participation if such holder does not have a shareholding of 5% or more but a related entity (statutorily defined
term) has a participation, or STM is a related entity (statutorily defined term);

&nbsp;&nbsp;&nbsp;&nbsp;(iii) a holder of Ordinary Shares in respect of which STM is required to apply the dividend withholding tax
exemption (*inhoudingsvrijstelling*) with respect to any income (*opbrengst*) derived from the Ordinary Shares (as defined in
Article 4 of the Dutch Dividend Withholding Tax Act 1965 (*Wet op de dividendbelasting*)). Generally, STM is required to apply, subject
to certain other requirements, the dividend withholding tax exemption if the holder of Ordinary Shares is an entity and holds an interest
of 5% or more in STM's nominal paid-up share capital;

&nbsp;&nbsp;&nbsp;&nbsp;(iv) pension funds, investment institutions (*fiscale beleggingsinstellingen*) and tax-exempt investment
institutions (*vrijgestelde beleggingsinstellingen*) (each as defined in the Dutch Corporate Income Tax Act 1969) and other entities
that are, in whole or in part, not subject to or exempt from Dutch corporate income tax, entities that have a function comparable to an
investment institution or a tax-exempt investment institution, as well as entities that are exempt from corporate income tax in their
country of residence, such country of residence being another state of the European Union, Norway, Liechtenstein, Iceland or any other
state with which The Netherlands has agreed to exchange information in line with international standards;

&nbsp;&nbsp;&nbsp;&nbsp;(v) a holder of Ordinary Shares if such holder is an individual for whom the Ordinary Shares or any benefit
derived from the Ordinary Shares is a remuneration or deemed to be a remuneration for (employment) activities performed by such holder
or certain individuals related to such holder (as defined in the Dutch Income Tax Act 2001); and

&nbsp;&nbsp;&nbsp;&nbsp;(vi) holders of Ordinary Shares that are entities resident in Aruba, Curaçao, or Sint Maarten, conducting
a business through a permanent establishment (*vaste inrichting*) or permanent representative (*vaste vertegenwoordiger*) in
Bonaire, Sint Eustatius, or Saba, to which the Ordinary Shares are attributable.

**Withholding Tax on Dividends**

*Regular Dutch Dividend Withholding Tax*

Dividends distributed by STM are generally subject to Dutch dividend withholding tax at a rate of 15%. Generally, STM is responsible for the withholding of such dividend withholding tax at source; the Dutch dividend withholding tax is for the account of the holder of Ordinary Shares.

The expression "dividends distributed" includes, but is not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;· distributions in cash or in kind, deemed and constructive distributions and repayments of paid-in capital
not recognized for Dutch dividend withholding tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;· liquidation proceeds, proceeds from the redemption of Ordinary Shares, or proceeds from the repurchase
of Ordinary Shares (other than as temporary portfolio investment; *tijdelijke belegging*) by STM or one of STM's subsidiaries
or other affiliated entities, in each case to the extent such proceeds exceed the average paid-in capital of those Ordinary Shares as
recognized for Dutch dividend withholding tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;· an amount equal to the nominal value of the Ordinary Shares issued or an increase of the nominal value
of the Ordinary Shares, to the extent that no related contribution, recognized for Dutch dividend withholding tax purposes, has been made
or will be made; and

&nbsp;&nbsp;&nbsp;&nbsp;· partial repayment of the paid-in capital recognized for Dutch dividend withholding tax purposes, if and
to the extent that STM has "net profits" (*zuivere winst*), unless (i) the STM's general meeting of shareholders
has resolved in advance to make such repayment and (ii) the nominal value of the Ordinary Shares concerned has been reduced by an equal
amount by way of an amendment to STM's Articles. The term "net profits" includes anticipated profits that
have yet to be realized.

Corporate legal entities that are resident or deemed to be resident of The Netherlands for Dutch corporate income tax purposes ("Dutch Resident Entities") generally are entitled to an exemption from, or a credit for, any Dutch dividend withholding tax against their Dutch corporate income tax liability. The credit in any given year is, however, limited to the amount of Dutch corporate income tax payable in respect of the relevant year with an indefinite carry forward of any excess amount. Individuals who are resident or deemed to be resident of The Netherlands for Dutch personal income tax purposes ("Dutch Resident Individuals") generally are entitled to a credit for any Dutch dividend withholding tax against their Dutch personal income tax liability and to a refund of any residual Dutch dividend withholding tax. The above generally also applies to holders of Ordinary Shares that are neither resident nor deemed to be resident of The Netherlands ("Non-Resident Holders") if the Ordinary Shares are attributable to a Dutch permanent establishment of such Non-Resident Holder.

A holder of Ordinary Shares resident of a country other than The Netherlands may, depending on such holder's specific circumstances, be entitled to exemptions from, reduction of, or full or partial refund of, Dutch dividend withholding tax under Dutch domestic tax law, EU law, or treaties for the avoidance of double taxation in effect between The Netherlands and such other country.

*Dividend stripping*

According to Dutch domestic anti-dividend stripping rules, no credit against Dutch tax, exemption from, reduction, or refund of Dutch dividend withholding tax will be granted if the recipient of the dividends STM paid is not considered the beneficial owner (*uiteindelijk gerechtigde*; as described in the Dutch Dividend Withholding Tax Act 1965) of those dividends. This legislation generally targets situations in which a shareholder retains its economic interest in shares but reduces the withholding tax costs on dividends by a transaction with another party. It is not required for these rules to apply that the recipient of the dividends is aware that a dividend stripping transaction took place. The Dutch State Secretary of Finance takes the position that the definition of beneficial ownership introduced by this legislation will also be applied in the context of a double taxation convention. The burden of proof with respect to beneficial ownership of dividends distributed by STM rests on the Dutch tax authorities. If, however, a shareholder would receive dividends, including dividends on the Ordinary Shares, in a calendar year in respect of which an aggregate amount of EUR 1,000 in Dutch dividend withholding tax would otherwise be due based on the rate of 15%, the burden of proof with respect to beneficial ownership of such dividends lies with the shareholder. Furthermore, for shares traded on a regulated market, including the Ordinary Shares, it has been codified that the record date is used when determining the person who is entitled to the dividend.

*Conditional Withholding Tax on Dividends*

In addition to the regular Dutch dividend withholding tax as described above, a Dutch conditional withholding tax will be imposed on dividends distributed by STM to a Related Entity (as defined below), if such Related Entity:

&nbsp;&nbsp;&nbsp;&nbsp;(i) is considered to be resident (*gevestigd*) in a jurisdiction that is listed in the yearly updated
Dutch Regulation on low-taxing states and non-cooperative jurisdictions for tax purposes (*Regeling laagbelastende staten en niet-coöperatieve rechtsgebieden voor belastingdoeleinden*) (a "Listed Jurisdiction"); or

&nbsp;&nbsp;&nbsp;&nbsp;(ii) has a permanent establishment located in a Listed Jurisdiction to which the Ordinary Shares are attributable;
or

&nbsp;&nbsp;&nbsp;&nbsp;(iii) holds the Ordinary Shares with the main purpose or one of the main purposes of avoiding taxation for another
person or entity and there is an artificial arrangement or transaction or a series of artificial arrangements or transactions; or

&nbsp;&nbsp;&nbsp;&nbsp;(iv) is not considered to be the beneficial owner of the Ordinary Shares in its jurisdiction of residence because
such jurisdiction treats another entity as the beneficial owner of the Ordinary Shares (a hybrid mismatch); or

&nbsp;&nbsp;&nbsp;&nbsp;(v) is not resident in any jurisdiction (also a hybrid mismatch); or

&nbsp;&nbsp;&nbsp;&nbsp;(vi) is a reverse hybrid (within the meaning of Article 2(11) of the Dutch Corporate Income Tax Act 1969),
if and to the extent (x) there is a participant in the reverse hybrid holding a Qualifying Interest in the reverse hybrid, (y) the jurisdiction
of residence of such participant treats the reverse hybrid as transparent for tax purposes and (z) such participant would have been subject
to the Dutch conditional withholding tax in respect of dividends distributed by STM without the interposition of the reverse hybrid,

all within the meaning of the Dutch Withholding Tax Act 2021 (*Wet bronbelasting 2021*).

For purposes of this section:

&nbsp;&nbsp;&nbsp;&nbsp;· "Related Entity" means an entity (i) that has a Qualifying Interest in the Company or (ii)
in which a third party has a Qualifying Interest if such third party also has a Qualifying Interest in the Company.

&nbsp;&nbsp;&nbsp;&nbsp;· "Qualifying Interest" means a direct or indirectly held interest – either by an entity
individually or, if an entity is part of a Qualifying Unity, jointly – that enables such entity or such Qualifying Unity to exercise
a definitive influence over another entity's decisions and allows it to determine that other entity's activities (as interpreted
by the European Court of Justice in case law on the right of freedom of establishment (*vrijheid van vestiging*)).

&nbsp;&nbsp;&nbsp;&nbsp;· "Qualifying Unity" means entities acting together with the main purpose or one of the main
purposes of avoiding Dutch conditional withholding tax at the level of any of those entities (*kwalificerende eenheid*).

The Dutch conditional withholding tax on dividends will be imposed at the highest Dutch corporate income tax rate in effect at the time of the distribution (2026: 25.8%). The Dutch conditional withholding tax on dividends will be reduced, but not below zero, by any regular Dutch dividend withholding tax withheld in respect of the same dividend distribution. As such, based on the currently applicable rates, the overall effective tax rate of withholding the regular Dutch dividend withholding tax (as described above) and the Dutch conditional withholding tax on dividends will not exceed the highest corporate income tax rate in effect at the time of the distribution (2026: 25.8%).

**Taxes on income and capital gains**

*Dutch Resident Entities*

Generally, if the holder of Ordinary Shares is a Dutch Resident Entity, any income derived or deemed to be derived from the Ordinary Shares or any capital gains realized on the disposal or deemed disposal or exercise, as applicable of the Ordinary Shares is subject to Dutch corporate income tax at a rate of 19% with respect to taxable profits up to €200,000 and 25.8% with respect to taxable profits in excess of that amount (rates and brackets for 2026).

*Dutch Resident Individuals*

If the holder of Ordinary Shares is a Dutch Resident Individual, any income derived or deemed to be derived from the Ordinary Shares or any capital gains realized on the disposal or deemed disposal or exercise, as applicable, of the Ordinary Shares is subject to Dutch personal income tax at the progressive rates (with a maximum of 49.5% in 2026), if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the Ordinary Shares are attributable to an enterprise from which the holder of Ordinary Shares derives
a share of the profit, whether as an entrepreneur (*ondernemer*) or as a person who has a co-entitlement to the net worth (*medegerechtigd tot het vermogen*) of such enterprise without being a shareholder (as defined in the Dutch Income Tax Act 2001);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the holder of Ordinary Shares is considered to perform activities with respect to the Ordinary Shares
that go beyond ordinary asset management (*normaal, actief vermogensbeheer*) or otherwise derives benefits from the Ordinary Shares
that are taxable as benefits from miscellaneous activities (*resultaat uit overige werkzaamheden*).

*Taxation of savings and investments*

If the above-mentioned conditions (i) and (ii) do not apply to the Dutch Resident Individual, the Ordinary Shares will be subject to an annual Dutch income tax under the regime for savings and investments (*inkomen uit sparen en beleggen*). Taxation only occurs insofar the Dutch Resident Individual's net investment assets for the year exceed a statutory threshold (*heffingvrij vermogen*). The net investment assets for the year are the fair market value of the investment assets less the fair market value of the liabilities on January 1 of the relevant calendar year (reference date; *peildatum*). Actual income or capital gains realized in respect of the Ordinary Shares are in principle not subject to Dutch income tax.

The Dutch Resident Individual's assets and liabilities taxed under this regime, including the Ordinary Shares, are allocated over the following three categories: (a) bank savings (*banktegoeden*), (b) other investments (*overige bezittingen*), including the Ordinary Shares, and (c) liabilities (*schulden*). The taxable benefit for the year (*voordeel uit sparen en beleggen*) is equal to the product of (x) the total deemed return divided by the sum of bank savings, other investments and liabilities and (y) the sum of bank savings, other investments and liabilities minus the statutory threshold, and is taxed at a flat rate of 36% (rate for 2026).

The deemed return applicable to other investments, including the Ordinary Shares, is set at 6.00% for the calendar year 2026. Transactions in the three-month period before and after January 1 of the relevant calendar year implemented to arbitrate between the deemed return percentages applicable to bank savings, other investments and liabilities will for this purpose be ignored if the holder of Ordinary Shares cannot sufficiently demonstrate that such transactions are implemented for other than tax reasons.

On June 6 and 14, 2024, the Dutch Supreme Court (*Hoge Raad*) ruled that the Dutch income tax regime for savings and investments as described above (the "Box 3 Regime") in certain specific circumstances contravenes with Section 1 of the First Protocol to the European Convention on Human Rights in combination with Section 14 of the European Convention on Human Rights (the "Rulings"). In the Rulings, the Dutch Supreme Court introduced a rebuttal provision (*tegenbewijsregeling*) pursuant to which taxpayers have the possibility to demonstrate that the actual return realized by the taxpayer in respect of their investments assets (as calculated in line with the rules as set out in the Rulings), is less than the deemed return realized by the taxpayer in respect of those assets (as calculated in accordance with the rules of the Box 3 Regime). The rebuttal provision introduced by the Dutch Supreme Court as well as the rules set out in the Rulings have been implemented in Dutch tax law pursuant to the Dutch Box 3 Rebuttal Scheme Act (*Wet tegenbewijsregeling box 3*). If the taxpayer successfully demonstrates that the actual return is less than the deemed return (using a standardized form), the taxpayer will be taxed on the actual return instead of the deemed return. The Dutch Box 3 Rebuttal Scheme Act offers a temporary solution until a new Box 3 regime is introduced, which is expected as of 1 January 2028 at the earliest.

Holders of Ordinary Shares are advised to consult their own tax advisor to ensure that the tax in respect of the Ordinary Shares is levied in accordance with the applicable Dutch tax rules at the relevant time.

*Non-residents of The Netherlands*

A holder of Ordinary Shares that is neither a Dutch Resident Entity nor a Dutch Resident Individual will not be subject to Dutch income tax in respect of income derived or deemed to be derived from the Ordinary Shares or in respect of capital gains realized on the disposal or deemed disposal or exercise, as applicable of the Ordinary Shares, provided that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) such holder does not have an interest in an enterprise or deemed enterprise (as defined in the Dutch Income
Tax Act 2001 and the Dutch Corporate Income Tax Act 1969, as applicable) which, in whole or in part, is either effectively managed in
The Netherlands or carried on through a permanent establishment, a deemed permanent establishment or a permanent representative in The
Netherlands and to which enterprise or part of an enterprise the Ordinary Shares are attributable; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) in the event the holder is an individual, such holder does not carry out any activities in The Netherlands
with respect to the Ordinary Shares that go beyond ordinary asset management and does not otherwise derive benefits from the Ordinary
Shares that are taxable as benefits from miscellaneous activities in the Netherlands.

**Gift and inheritance taxes**

*Residents of The Netherlands*

Gift or inheritance taxes will arise in The Netherlands with respect to a transfer of Ordinary Shares by way of a gift by, or on the death of, a holder of Ordinary Shares who is resident or deemed resident of The Netherlands at the time of the gift or such holder's death.

*Non-residents of The Netherlands*

No gift or inheritance taxes will arise in The Netherlands with respect to a transfer of Ordinary Shares by way of a gift by, or on the death of, a holder of Ordinary Shares who is neither resident nor deemed to be resident of The Netherlands, unless:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) in the case of a gift of an Ordinary Share by an individual who at the date of the gift was neither resident
nor deemed to be resident of The Netherlands, such individual dies within 180 days after the date of the gift, while being resident or
deemed to be resident of The Netherlands; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) in the case of a gift of an Ordinary Share is made under a condition precedent, the holder of Ordinary
Shares is resident or is deemed to be resident of The Netherlands at the time the condition is fulfilled; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the transfer is otherwise construed as a gift or inheritance made by, or on behalf of, a person who, at
the time of the gift or death, is or is deemed to be resident of The Netherlands.

For purposes of Dutch gift and inheritance taxes, amongst others, a person that holds the Dutch nationality will be deemed to be resident of The Netherlands if such person has been a resident of The Netherlands at any time during the ten years preceding the date of the gift or such person's death. Additionally, for purposes of Dutch gift tax, amongst others, a person not holding the Dutch nationality will be deemed to be resident of The Netherlands if such person has been a resident of The Netherlands at any time during the twelve months preceding the date of the gift. Applicable tax treaties may override deemed residency.

**Value added tax ("VAT")**

No Dutch VAT will be payable by a holder of Ordinary Shares in respect of any payment in consideration for the holding or disposal or exercise, as applicable of the Ordinary Shares.

**Real Property Transfer Tax**

Under circumstances, the Ordinary Shares could, for the purposes of Dutch real property transfer tax (*overdrachtsbelasting*), be treated as real property (*fictieve onroerende zaken*) located in The Netherlands, in which case this tax could be payable upon acquisition of Ordinary Shares.

The Ordinary Shares will generally not be treated as real property if at the time of, or at any time during the year preceding, the acquisition of the Ordinary Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) our assets do not and did not include real property situated in The Netherlands; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) our assets only include and included real property, situated either in or outside The Netherlands, that
STM does not and did not hold, and currently do not intend to hold, predominantly as a financial investment.

Real property as referred to under (i) and (ii) above includes legal ownership and more limited legal rights over the property (rights in rem) (*zakelijke rechten*) as well as contractual rights that give STM economic exposure to the value of such real property, and certain participations or interests in entities that are treated as real property.

Whilst our assets include and have included real property as described elsewhere in this prospectus, these properties are and have been exclusively used for our operational business activities, and we did not hold, and currently do not intend to hold, any interest in real property as a financial investment. Our assets do not include and have not included real property situated in The Netherlands as described above.

Consequently, no Dutch real property transfer tax becomes payable upon an acquisition of the Ordinary Shares.

**Stamp Duties**

No Dutch documentation taxes (commonly referred to as stamp duties) will be payable by a holder of Ordinary Shares in respect of any payment in consideration for the holding or disposal or exercise, as applicable, of the Ordinary Shares.

**PLAN OF DISTRIBUTION**

We are registering the offer and resale by the Selling Securityholder of 24,755,584 Ordinary Shares of STM that may be issued upon the exercise of the Warrants at an exercise price of $28.38 per share, subject to adjustments.

**Offer and Resale by Selling Securityholder**

The Selling Securityholder will pay any underwriting discounts and commissions and any transfer taxes and expenses incurred by the Selling Securityholder in connection with the sale of its Ordinary Shares further to any registration. We will bear all other costs, fees and expenses incurred in effecting the registration of the securities covered by this prospectus, including, without limitation, all registration and filing fees, NYSE listing fees and fees and expenses of our counsel and our independent registered public accountants.

The securities beneficially owned by the Selling Securityholder covered by this prospectus may be offered and sold from time to time by the Selling Securityholder. The term "Selling Securityholder" includes donees, pledgees, transferees or other successors in interest selling securities received after the date of this prospectus from a Selling Securityholder as a gift, pledge, partnership distribution or other transfer. The Selling Securityholder will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices related to the then current market price or in negotiated transactions. Each Selling Securityholder reserves the right to accept and, together with its respective agents, to reject, any proposed purchase of securities to be made directly or through agents. The Selling Securityholder and any of their permitted transferees may sell their securities offered by this prospectus on any stock exchange, market or trading facility on which the securities are traded or in private transactions. If underwriters are used in the sale, such underwriters will acquire the shares for their own account. These sales may be at a fixed price or varying prices, which may be changed, or at market prices prevailing at the time of sale, at prices relating to prevailing market prices or at negotiated prices. The securities may be offered to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. The obligations of the underwriters to purchase the securities will be subject to certain conditions. The underwriters will be obligated to purchase all the securities offered if any of the securities are purchased.

Subject to the limitations set forth in any applicable registration rights agreement, the Selling Securityholder may use any one or more of the following methods when selling the securities offered by this prospectus:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• purchases by a broker-dealer as principal and resale by such broker-dealer
for its own account pursuant to this prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ordinary brokerage transactions and transactions in which the broker solicits
purchasers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• block trades in which the broker-dealer so engaged will attempt to sell
the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an over-the-counter distribution in accordance with the rules of the NYSE;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• through trading plans entered into by a Selling Securityholder pursuant
to Rule 10b5-l under the Exchange Act that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus
hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• through one or more underwritten offerings on a firm commitment or best
efforts basis;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• settlement of short sales entered into after the date of this prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• agreements with broker-dealers to sell a specified number of the securities
at a stipulated price per share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• in "at the market" offerings, as defined in Rule 415 under the
Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices,
including sales made directly on a national securities exchange or sales made through a market maker other than

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• on an exchange or other similar offerings through sales agents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• directly to purchasers, including through a specific bidding, auction or
other process or in privately negotiated transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• through the writing or settlement of options or other hedging transactions,
whether through an options exchange or otherwise;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• through a combination of any of the above methods of sale; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any other method permitted pursuant to applicable law.

There can be no assurance that the Selling Securityholder will sell all or any of the securities offered by this prospectus. In addition, the Selling Securityholder may also sell securities under Rule 144 under the Securities Act, if available, or in other transactions exempt from registration, rather than under this prospectus. The Selling Securityholder have the sole and absolute discretion not to accept any purchase offer or make any sale of securities if they deem the purchase price to be unsatisfactory at any particular time.

The Selling Securityholder also may transfer the securities in other circumstances, in which case the transferees, pledgees or other successors-in-interest will be the selling beneficial owners for purposes of this prospectus. Upon being notified by a Selling Securityholder that a donee, pledgee, transferee, other successor- in-interest intends to sell our securities, we will, to the extent required, promptly file a supplement to this prospectus to name specifically such person as a selling securityholder.

With respect to a particular offering of the securities held by the Selling Securityholder, to the extent required, an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement of which this prospectus is part, will be prepared and will set forth the following information:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the specific securities to be offered and sold;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the name of the Selling Securityholder;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the respective purchase prices and public offering prices, the proceeds
to be received from the sale, if any, and other material terms of the offering;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• settlement of short sales entered into after the date of this prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the names of any participating agents, broker-dealers or underwriters; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any applicable commissions, discounts, concessions and other items constituting
compensation from the Selling Securityholder.

In connection with distributions of the securities or otherwise, the Selling Securityholder may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of the securities in the course of hedging the positions they assume with Selling Securityholder. The Selling Securityholder may also sell the securities short and redeliver the securities to close out such short positions. The Selling Securityholder may also enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The Selling Securityholder may also pledge securities to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged securities pursuant to this prospectus (as supplemented or amended to reflect such transaction).

In order to facilitate the offering of the securities, any underwriters or agents, as the case may be, involved in the offering of such securities may engage in transactions that stabilize, maintain or otherwise affect the price of our securities. Specifically, the underwriters or agents, as the case may be, may overallot in connection with the offering, creating a short position in our securities for their own account. In addition, to cover overallotments or to stabilize the price of our securities, the underwriters or agents, as the case may be, may bid for, and purchase, such securities in the open market. Finally, in any offering of securities through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allotted to an underwriter or a broker-dealer for distributing such securities in the offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. The underwriters or agents, as the case may be, are not required to engage in these activities, and may end any of these activities at any time.

The Selling Securityholder may solicit offers to purchase the securities directly from, and it may sell such securities directly to, institutional investors or others. In this case, no underwriters or agents would be involved. The terms of any of those sales, including the terms of any bidding or auction process, if utilized, will be described in the applicable prospectus supplement.

It is possible that one or more underwriters may make a market in our securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We cannot give any assurance as to the liquidity of the trading market for our securities. Our Ordinary Shares are currently listed on the NYSE under the symbol "STM".

The Selling Securityholder may authorize underwriters, broker-dealers or agents to solicit offers by certain purchasers to purchase the securities at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any commissions we or the Selling Securityholder pay for solicitation of these contracts.

A Selling Securityholder may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus, including in short sale transactions. If so, the third party may use securities pledged by any Selling Securityholder or borrowed from any Selling Securityholder or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from any Selling Securityholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, any Selling Securityholder may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.

In effecting sales, broker-dealers or agents engaged by the Selling Securityholder may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the Selling Securityholder in amounts to be negotiated immediately prior to the sale.

In compliance with the guidelines of the Financial Industry Regulatory Authority ("FINRA"), the aggregate maximum discount, commission, fees or other items constituting underwriting compensation to be received by any FINRA member or independent broker-dealer will not exceed 8% of the gross proceeds of any offering pursuant to this prospectus and any applicable prospectus supplement .

If at the time of any offering made under this prospectus a member of FINRA participating in the offering has a "conflict of interest" as defined in FINRA Rule 5121 ("Rule 5121"), that offering will be conducted in accordance with the relevant provisions of Rule 5121.

To our knowledge, there are currently no plans, arrangements or understandings between the Selling Securityholder and any broker-dealer or agent regarding the sale of the securities by the Selling Securityholder. Upon our notification by a Selling Securityholder that any material arrangement has been entered into with an underwriter or broker-dealer for the sale of securities through a block trade, special offering, exchange distribution, secondary distribution or a purchase by an underwriter or broker-dealer, we will file, if required by applicable law or regulation, a supplement to this prospectus pursuant to Rule 424(b) under the Securities Act disclosing certain material information relating to such underwriter or broker-dealer and such offering.

Underwriters, broker-dealers or agents may facilitate the marketing of an offering online directly or through one of their affiliates. In those cases, prospective investors may view offering terms and a prospectus online and, depending upon the particular underwriter, broker-dealer or agent, place orders online or through their financial advisors.

In offering the securities covered by this prospectus, if any of the Selling Securityholder or any underwriters, broker-dealers or agents who execute sales for the Selling Securityholder are deemed to be "underwriters" within the meaning of the Securities Act in connection with such sales, any discounts, commissions, concessions or profit they earn on any resale of those securities may be underwriting discounts and commissions under the Securities Act.

The underwriters, broker-dealers and agents may engage in transactions with us or the Selling Securityholder, or perform services for us or the Selling Securityholder, in the ordinary course of business.

In order to comply with the securities laws of certain states, if applicable, the securities must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

The Selling Securityholder and any other persons participating in the sale or distribution of the securities will be subject to applicable provisions of the Securities Act and the Exchange Act, and the rules and regulations thereunder, including, without limitation, Regulation M. These provisions may restrict certain activities of, and limit the timing of purchases and sales of any of the securities by, the Selling Securityholder or any other person, which limitations may affect the marketability of the shares of the securities.

We will make copies of this prospectus available to the Selling Securityholder for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The Selling Securityholder may indemnify any agent, broker-dealer or underwriter that participates in transactions involving the sale of the securities against certain liabilities, including liabilities arising under the Securities Act.

We have agreed to indemnify the Selling Securityholder against certain liabilities, including certain liabilities under the Securities Act, the Exchange Act or other federal or state law. Agents, broker-dealers and underwriters may be entitled to indemnification by us and the Selling Securityholder against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which the agents, broker-dealers or underwriters may be required to make in respect thereof.

**EXPENSES RELATED TO THE OFFERING**

Set forth below is an itemization of the total expenses that are expected to be incurred by us in connection with the offering. We will pay the fees and expenses associated with the sale of Ordinary Shares pursuant to this prospectus, other than underwriting discounts and commissions and any transfer taxes and expenses incurred by the Selling Securityholder in connection with the sale of its Ordinary Shares further to any registration. With the exception of the SEC registration fee, all amounts are estimates.

---

| | |
|:---|:---|
|  | $ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SEC Registration Fee | 109228.94 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal Fees and Expenses | 30000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounting Fees and Expenses | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous Expenses | 5000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**To** **tal** | 154228.94 |

---

**LEGAL MATTERS**

The validity of the Ordinary Shares offered by this prospectus has been passed upon by NautaDutilh N.V., Beethovenstraat 400, 1082 PR Amsterdam, The Netherlands, Dutch counsel to the Company.

**INTERESTS OF EXPERTS AND COUNSEL**

None.

**EXPERTS**

The consolidated financial statements of STMicroelectronics N.V. appearing in STMicroelectronics N.V.'s Annual Report (Form 20-F) for the year ended December 31, 2025, and the effectiveness of STMicroelectronics N.V.'s internal control over financial reporting as of December 31, 2025 have been audited by Ernst & Young AG, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

**ENFORCEMENT OF CIVIL LIABILITIES**

We are organized and existing under the laws of The Netherlands. As such, under Dutch private international law, the rights and obligations of our shareholders vis-à-vis the Company originating from Dutch corporate law and our Articles, as well as the civil liability of our officers (*functionarissen*) (including our directors and executive officers) are governed in certain respects by the laws of The Netherlands.

We are not a resident of the United States and our officers may also not all be residents of the United States. As a result, depending on the subject matter of the action brought against us and/or our officers, United States courts may not have jurisdiction. If a Dutch court has jurisdiction with respect to such action, that court will apply Dutch procedural law and Dutch private international law to determine the law applicable to that action. Depending on the subject matter of the relevant action, a competent Dutch court may apply another law than the laws of the United States.

Also, service of process against non-residents of the United States can in principle (absent, for example, a valid choice of domicile) not be effected in the United States.

Furthermore, a substantial amount of our assets are located outside the United States. As of the date of this prospectus, (i) there is no treaty in force between the United States and The Netherlands for the reciprocal recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters and (ii) both the Hague Convention on Choice of Court Agreements (2005) and the Hague Judgments Convention (2019) have entered into force for The Netherlands, but have not entered into force for the United States. Consequently, a judgment rendered by a court in the United States will not automatically be recognized and enforced by the competent Dutch courts. However, if a person has obtained a judgment rendered by a court in the United States that is enforceable under the laws of the United States and files a claim with the competent Dutch court, the Dutch court will in principle give binding effect to that United States judgment if (i) the jurisdiction of the United States court was based on a ground of jurisdiction that is generally acceptable according to international standards, (ii) the judgment by the United States court was rendered in legal proceedings that comply with the Dutch standards of proper administration of justice including sufficient safeguards (*behoorlijke rechtspleging*), (iii) binding effect of such United States judgment is not contrary to Dutch public order (*openbare orde*) and (iv) the judgment by the United States court is not incompatible with a decision rendered between the same parties by a Dutch court, or with a previous decision rendered between the same parties by a foreign court in a dispute that concerns the same subject and is based on the same cause, provided that the previous decision qualifies for recognition in The Netherlands. Even if such a United States judgment is given binding effect, a claim based thereon may, however, still be rejected if the United States judgment is not or no longer formally enforceable. Moreover, if the United States judgment is not final (for instance when appeal is possible or pending) a competent Dutch court may postpone recognition until the United States judgment will have become final, refuse recognition under the understanding that recognition can be asked again once the United States judgment will have become final, or impose as a condition for recognition that security is posted.

A competent Dutch court may deny the recognition and enforcement of punitive damages or other awards. Moreover, a competent Dutch court may reduce the amount of damages granted by a United States court and recognize damages only to the extent that they are necessary to compensate actual losses or damages. Finally, there may be specific other instances, including pursuant to anti-boycott rules and regulations, where Dutch law prohibits the recognition and enforcement of a United States judgment. Thus, United States investors may not be able to enforce, or may experience difficulty in enforcing, a judgment obtained in a United States court against us or our officers.

**WHERE YOU CAN FIND MORE INFORMATION**

We are subject to the periodic reporting and other information requirements of the Exchange Act as applicable to a "foreign private issuer," and we will file annual reports and other information from time to time with the SEC in accordance with such requirements. Our SEC filings will be available to the public on the internet at a website maintained by the SEC located at www.sec.gov.

This prospectus, which is part of the registration statement, does not contain all of the information set forth in the registration statement and the exhibits and schedules to the registration statement. We have omitted parts of the registration statement in accordance with the rules and regulations of the SEC. For more detail about us and the securities that may be offered by this prospectus, you may examine the registration statement on Form F-3 and the exhibits filed with it at the website provided in the previous paragraph.

We also maintain a website at https://www.st.com. We will make available, free of charge, the following documents as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC: our annual reports on Form 20-F; our reports on Form 6-K; amendments to these documents; and other information as may be required by the SEC. The information contained on, or that may be accessed through, our website is not part of, and is not incorporated into, this prospectus.

**INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE**

The SEC allows us to incorporate by reference in this prospectus the information we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Any statement made in this prospectus or in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus, the accompanying prospectus supplement, if applicable, or in any other subsequently filed document that is also incorporated or deemed to be incorporated by reference in this prospectus modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus. Therefore, before you decide to invest in a particular offering under this shelf registration statement, you should always check for reports we may have filed with the SEC after the date of this prospectus. We incorporate by reference in this prospectus the following information:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the SEC on February 26, 2026.

All subsequent annual reports on Form 20-F that we file with the SEC prior to the completion or termination of this offering shall be deemed to be incorporated by reference to this prospectus and to be a part hereof from the date of filing of such documents. We may also incorporate by reference part or all of any reports on Form 6-K that we subsequently furnish to the SEC prior to the completion or termination of this offering by identifying in such Forms 6-K that they, or certain parts of their contents, are as being incorporated by reference into this prospectus and any Forms 6-K so identified shall be deemed to be incorporated by reference in this prospectus and to be a part of this prospectus from the date of submission of such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.

The information we incorporate by reference is an important part of this prospectus, and later information that we file with the SEC will automatically update and supersede the information contained in this prospectus.

You should not assume that the information in this prospectus, any prospectus supplement or any document incorporated by reference is accurate or complete at any date other than the date mentioned on the cover page of those documents or otherwise specified therein.

We file reports, including annual reports on Form 20-F and reports on Form 6-K, with the SEC pursuant to the rules and regulations of the SEC that apply to foreign private issuers. You can read our SEC filings, including the registration statement, over the internet at the SEC's website at www.sec.gov and at our website at https://www.st.com/content/st_com/en.html. We do not incorporate the information contained on, or accessible through, the Company's websites into this prospectus, and you should not consider it as a part of this prospectus.

You may request a copy of any and all of the information that has been incorporated by reference in this prospectus but not delivered with the prospectus, at no cost, upon written or oral request made to STMicroelectronics N.V., WTC Schiphol Airport, Schiphol Boulevard 265, 1118 BH Schiphol, The Netherlands, Tel: +31-20-654-3210; Attention: Steven Rose, President, Legal Counsel and Public Affairs.

**PART II. INFORMATION NOT REQUIRED IN PROSPECTUS**

**Item 8. Indemnification of Directors and Officers**

Under Dutch law, our Managing Board and certain other officers may be held liable for damages in the event of improper or negligent performance of their duties. They may be held jointly and severally liable for damages to our company and to third parties for infringement of the Articles or of certain provisions of the Dutch Civil Code.

In certain circumstances, they may also incur additional specific civil and criminal liabilities. Directors and certain other officers are insured under an insurance policy taken out by us against damages resulting from their conduct when acting in the capacities as such directors or officers. In addition, our Articles provide for indemnification of our directors, including reimbursement for reasonable legal fees and damages or fines based on acts or failures to act in their duties. No indemnification shall be given to a member of our Managing Board if a Dutch court has established, without possibility for appeal, that the acts or omissions of such indemnified person that led to the financial losses, damages, suit, claim, action or legal proceedings resulted from either an improper performance of his or her duties as a director or an officer of our company or an unlawful or illegal act, and only to the extent that his or her financial losses, damages and expenses are covered by an insurance and the insurer has settled these financial losses, damages and expenses (or has indicated that it would do so).

Furthermore, such indemnification will generally not be available in instances of willful (*opzettelijk*), intentionally reckless (*bewust roekeloos*) or seriously culpable (*ernstig verwijtbaar*) conduct unless Dutch law provides otherwise.

**Item 9. Exhibits and Financial Statement Schedules**

---

| | |
|:---|:---|
| **Exhibit**<br> **Number** | **Description** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1\* | [Articles of Association.](ss6108090_ex0401.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1\* | [Legal Opinion of NautaDutilh N.V.](ss6108090_ex0501.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.1\* | [Consent of Ernst & Young AG.](ss6108090_ex2301.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.2\* | [Consent of NautaDutilh N.V. (included in Exhibit 5.1).](ss6108090_ex0501.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24.1 | [Powers of Attorney (included on the signature page hereto).](#poa) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;107\* | [Filing Fee Table.](ss6108090_ex107.htm) |

---

\* Filed herewith.

# Certain schedules, annexes and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K, but will be furnished supplementally to the SEC upon request.

† Ordinary Shares are in uncertificated form. Therefore STM is not filing a specimen certificate evidencing Ordinary Share.

**Item 10. Undertakings**

**A.** **STM hereby undertakes:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file , during any period in which offers or sales are being made, a post-effective amendment to
this registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section 10(a)(3) of the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most recent post-effective amendment thereof) that, individually or in
the aggregate , represent a fundamental
change in the information set forth in the registration statement. Notwithstanding the foregoing , any increase or decrease in volume of securities offered (if the total dollar value
of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected
in the form of prospectus filed with the SEC pursuant to Rule 424(b) if , in
the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth
in the "Calculation of Registration Fee" table in the effective registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement.

provided, however, that paragraphs (a)(l)(i), (a)(l)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under
the Securities Act, each such post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating
to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) To file a post-effective amendment to the registration statement
to include any financial statements required by Item 8.A of Form 20-F at the start of any delayed offering or throughout a continuous
offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished; provided,
that the registrant includes in the prospectus, by means of a post- effective amendment, financial statements required pursuant to this
paragraph and other information necessary to ensure that all other information in the prospectus is at least as current as the date of
those financial statements. Notwithstanding the foregoing, a post-effective amendment need not be filed to include financial statements
and information required by Section 10(a)(3) of the Securities Act or Item 8.A of Form 20-F if such financial statements and information
are contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d)
of the Exchange Act that are incorporated by reference in the Form F-3;and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) That, for the purpose of determining liability under the
Securities Act to any purchaser :

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) each prospectu s filed by the re g istrant
pursuant to Rule 424(b)(3) sh a ll
be deemed to be p a rt of the
regi s tration statement a s o f the
d a te the filed pro s pectu s was deemed part o f and included i n the r e g istrat i on s tatement ; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) each prospectus required to be filed pursuant to Rule 424(b)(2) , (b)(5) , or (b) (7) as part of a registration statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(l)(i), (vii) , or
(x) for the purpose of providing
the information required by section IO(a) of the Securities Act shall be deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus.
As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter , such date shall be deemed to be a new effective date of the registration statement relating
to the securities in the registration statement to which that prospectus relate s ,
and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that
no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated
or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as
to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) that, for the p u rpose of determining liability of the registrant under the Securities Act to any purchaser in
the initia l distribution of the securities:

The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Any preliminary prospectus or prospectus of the undersigned registrant relating
to the offering required to be filed pursuant to Rule 424;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Any free writing prospectus relating to the offering prepared by or on behalf
of the undersigned registrant or used or referred to by the undersigned registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The portion of any other free writing prospectus relating
to the offering containing material information about the undersigned registrant or its securities provided by or on beha l f
of the undersigned registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Any other communication that is an offer in the offering made by the undersigned
registrant to the purchaser.

&nbsp;&nbsp;&nbsp;&nbsp;**B.** **STM** **hereby undertakes :** that,
for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the registration statement
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registrations statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Amsterdam, The Netherlands on March 25, 2026.

---

| | |
|:---|:---|
| **STMicroelectronics N.V.** | **STMicroelectronics N.V.** |
| By: | /s/ Jean Marc Chery |
| Name: | Jean Marc Chery |
| Title: | President and Chief Executive Officer,<br> Chairman of the Managing Board |

---

**POWER OF ATTORNEY**

Each of the undersigned individuals hereby severally constitutes and appoints each of Philippe Dereeper, Giuseppe Amodio, Denise Tuinfort and any one or more of them as the attorney-in-fact and agent for the undersigned, in any and all capacities, with full power of substitution and re-substitution, to sign any and all pre- or post-effective amendments to this registration statement, any subsequent registration statement for the same offering which may be filed pursuant to Rule 462 under the U.S. Securities Act of 1933, as amended, and any and all pre- or post-effective amendments thereto, and to file the same with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the U.S. Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | | |
|:---|:---|:---|:---|
| **Signature** | **Name** | **Title** | **Date** |
| <u>/s/ Jean Marc Chery</u> | Jean Marc Chery | President and Chief Executive Officer, <br> and Chairman of the Managing Board | March 25, 2026 |
| <u>/s/ Lorenzo Grandi</u> | Lorenzo Grandi | President and Chief Financial Officer, <br> and Member of the Managing Board | March 25, 2026 |
| <u>/s/ Thierry Vigne</u>  | Thierry Vigne | Chief Accounting Officer | March 25, 2026 |
| <u>/s/ Nicolas Dufourcq</u> | Nicolas Dufourcq | Chairman of the Supervisory Board | March 25, 2026 |
| <u>/s/ Armando Varricchio</u> | Armando Varricchio | Vice Chairman of the Supervisory Board | March 25, 2026 |
| <u>/s/ Simonetta Acri</u> | Simonetta Acri | Member of the Supervisory Board | March 25, 2026 |
| <u>/s/ Orio Bellezza</u> | Orio Bellezza | Member of the Supervisory Board | March 25, 2026 |
| <u> </u> | Pascal Daloz | Member of the Supervisory Board | March 25, 2026 |
| <u> </u> | Ana de Pro Gonzalo | Member of the Supervisory Board | March 25, 2026 |
| <u>/s/ Werner Lieberherr</u> | Werner Lieberherr | Member of the Supervisory Board | March 25, 2026 |
| <u>/s/ Frédéric Sanchez</u> | Frédéric Sanchez | Member of the Supervisory Board | March 25, 2026 |
| <u>/s/ Hélène Vletter-van Dort</u> | Hélène Vletter-van Dort | Member of the Supervisory Board | March 25, 2026 |

---

**AUTHORIZED REPRESENTATIVE**

Pursuant to the requirements of Section 6(a) of the U.S. Securities Act of 1933, as amended, this registration statement has been signed on behalf of the registrant by the undersigned, solely in his capacity as the duly authorized representative of the registrant in the United States, on March 25, 2026.

---

| | |
|:---|:---|
| **STMicroelectronics N.V.** | **STMicroelectronics N.V.** |
| By: | /s/ Rino Peruzzi |
| Name: | Rino Peruzzi |

---

## Exhibit 4.1

![](image_002.jpg)

**STMicroelectronics N.V.**

Articles of Association

(translation into English of the original Dutch text)

![](image_001.jpg)

*This is a translation into English of the official Dutch version of a deed of amendment to the articles of association of a public limited liability company under Dutch law. In the event of a conflict between the English and Dutch texts, the Dutch text shall prevail.*

**DEED OF AMENDMENT TO THE ARTICLES OF ASSOCIATION OF**

**STMicroelectronics N.V.**

On this day, the twenty-second day of May two thousand and twenty-four, appeared before me, Paul Cornelis Simon van der Bijl, civil law notary at Amsterdam:

Mechteld Suzette Flohil, born in 's-Gravenhage, on the twenty-first day of September nineteen hundred and eighty-one, working at the offices of NautaDutilh N.V. located at Beethovenstraat 400, 1082 PR Amsterdam.

I, civil law notary, attended a general meeting, held on the date hereof, of **STMicroelectronics N.V.**, a public limited liability company, having its corporate seat at Amsterdam (address: Schiphol Boulevard 265, 1118 BH Schiphol, trade register number: 33194537) (the "**Company**"), where it was resolved to amend the Company's articles of association in their entirety as set out below.

The Company's articles of association were most recently amended by a deed executed on the twentieth day of June two thousand and seventeen, before Wijnand Hendrik Bossenbroek, civil law notary at Amsterdam.

In order to carry out the abovementioned resolution to amend the articles of association, the person appearing declared to amend the Company's articles of association in their entirety, as set out below:

**<u>Name, seat and duration.</u>**

**<u>Article 1.</u>**

1.1. The name of the company is: STMicroelectronics N.V.

1.2. The company is established in Amsterdam.

1.3. The company will continue for an indefinite period.

**<u>Objects</u>.**

**<u>Article 2.</u>**

The objects of the company shall be to participate or take in any manner any interests in other business enterprises, to manage such enterprises, to carry on the business in semi-conductors and electronic devices, to take and grant licenses and other industrial property interests, assume commitments in the name of any enterprises with which it may be associated within a group of companies, to take financial interests in such enterprises and to take any other action, such as but not limited to the granting of securities or the undertaking of obligations on behalf of third parties, which in the broadest sense of the term, may be related or contribute to the aforesaid objects.

**<u>Share capital.</u>**

**<u>Article 3.</u>**

3.1. The authorized capital of the company amounts to one billion eight hundred nine million six hundred
thousand euro (EUR 1,809,600,000), consisting of one billion two hundred million (1,200,000,000) ordinary shares and five hundred forty
million (540,000,000) cumulative preference shares, hereinafter referred to as: preference shares, of one euro and four eurocents (EUR
1.04) each.

![](image_001.jpg)

3.2. Where in these articles of association reference is made to shares and shareholders this shall include
the shares of each class as well as the holders of shares of each class respectively, unless explicitly provided otherwise.

**<u>Issue of shares.</u>**

**<u>Article 4.</u>**

4.1. The supervisory board shall have the power to issue shares and to determine the terms and conditions
of such issue if and in so far as the supervisory board has been designated by the general meeting of shareholders as the authorized body
for this purpose. A designation as referred to above shall only take place for a specific period of no more than five years and may not
be extended by more than five years on each occasion.

4.2. If a designation as referred to in the first paragraph is not in force, the general meeting of shareholders
shall have the power, upon the proposal of and on the terms and conditions set by the supervisory board to resolve to issue shares.

4.3. In the event of an issue of ordinary shares, shareholders shall have a pre-emptive right in proportion
to the number of ordinary shares which they own, notwithstanding the provisions of the law. In respect of the issue of shares there shall
be no pre-emptive right to shares issued against a contribution other than in cash or issued to employees of the company or of a group
company.

In the event of an issue of preference shares none of the shareholders shall have a pre-emptive right.

The supervisory board shall have the power to limit or exclude the pre-emptive right accruing to shareholders, if and in so far as the supervisory board has also been designated by the general meeting of shareholders for this purpose as the authorized body for the period of such designation. The provisions in the second sentence of the first paragraph shall equally apply.

4.4. If a designation as referred to in the third paragraph is not in force, the general meeting of shareholders
shall have the power, upon the proposal of the supervisory board, to limit or exclude the pre-emptive right accruing to shareholders.

4.5. A resolution of the general meeting of shareholders to limit or exclude pre-emptive rights or to designate
the supervisory board as authorized to resolve upon limiting or excluding of pre-emptive rights requires a majority of at least two-thirds
of the votes cast in a meeting if in such meeting less than one-half of the issued share capital is present or represented.

4.6. Without prejudice to what has been provided in section 80, paragraph 2, Book 2, Dutch Civil Code shares
shall at no time be issued below par.

4.7. Ordinary shares shall be issued only against payment in full; preference shares may be issued against
partial payment, provided that the proportion of the nominal amount that must be paid on each preference share, irrespective of when it
was issued, shall be the same and that at least one quarter of the nominal amount is paid up in full when the share is subscribed for.

![](image_001.jpg)

4.8. Payment must be made in cash to the extent that no other contribution has been agreed upon. If the
company so consents, payment in cash can be made in a foreign currency.

In the event of payment in a foreign currency the obligation to pay is for the amount which can be freely exchanged into Dutch currency. The decisive factor is the rate of exchange on the day of payment, or as the case may be after application of the next sentence, on the day mentioned therein. The company can require payment at the rate of exchange on a certain day within two months prior to the last day when payment shall have to be made provided that the shares or depositary receipts for shares after having been issued - shall immediately be incorporated in the price list of an exchange abroad.

4.9. This article shall equally apply to the granting of rights to subscribe for shares, but shall not apply
to the issue of shares to someone who exercises a previously acquired right to subscribe for shares.

4.10. The managing board shall determine, subject to the approval by the supervisory board, when and in what
amount further payment is to be made in respect of partially paid preference shares. The managing board shall notify the shareholders
concerned thereof in writing at least thirty days before the date on which the payment must finally be made.

4.11. The provisions of article 27 paragraph 2 shall apply accordingly to all notifications to shareholders.

**<u>Repurchase and cancellation of shares.</u>**

**<u>Article 5.</u>**

5.1. The company may acquire, for valuable consideration, shares in its own share capital if and in so far
as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. its equity less the purchase price of these shares is not less than the aggregate amount of the paid
up and called up capital and the reserves which must be maintained pursuant to the law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the par value of the shares in its capital which the company acquires, holds or holds in pledge, or
which are held by a subsidiary company, amounts to no more than one-tenth of the issued share capital; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. the general meeting of shareholders has authorized the managing board to acquire such shares,
which authorization may be given for no more than eighteen months on each occasion,

notwithstanding the further statutory provisions.

5.2. The company may, without being authorized thereto by the general meeting of shareholders and notwithstanding
to what is provided in paragraph 1 under a and b, acquire shares in its own share capital in order to transfer those shares to the employees
of the company or a group company under a scheme applicable to such employees.

5.3. Shares thus acquired may again be disposed of. The company shall not acquire shares in its own share
capital as referred to in paragraph 1 - if an authorization as referred to in such paragraph is in force - or as referred to in paragraph
2 without the prior approval of the supervisory board. The company shall also not dispose of shares in its own share capital - with the
exception of shares in the company's own share capital acquired pursuant to paragraph 2 - without the prior approval of the supervisory
board.

![](image_001.jpg)

If depositary receipts for shares in the company have been issued, such depositary receipts shall for the application of the provisions of this paragraph and the preceding paragraph be treated as shares.

5.4. In the general meeting of shareholders no votes may be cast in respect of (a) share(s) held by the
company or a subsidiary company; no votes may be cast in respect of a share the depositary receipt for which is held by the company or
a subsidiary company. However, the holders of a right of usufruct and the holders of a right of pledge on shares held by the company and
its subsidiary companies, are nonetheless not excluded from the right to vote such shares, if the right of usufruct or the right of pledge
was granted prior to the time such share was held by the company or a subsidiary company. Neither the company nor a subsidiary company
may cast votes in respect of a share on which it holds a right of usufruct or a right of pledge.

Shares in respect of which voting rights may not be exercised by law or by the articles of association shall not be taken into account, when determining to what extent the shareholders cast votes, to what extent they are present or represented or to what extent the share capital is provided or represented.

5.5. Upon the proposal of the supervisory board the general meeting of shareholders shall, with due regard
of the provisions of section 99, Book 2, Dutch Civil Code, have the power to decide to reduce the issued share capital by cancelling shares
or by reducing the par value of shares by an amendment to the articles of association. Cancellation of shares with repayment or partial
repayment or a release from the obligation to pay up may also take place solely in respect of preference shares. In case of cancellation
of preference shares with repayment, a payment on the relevant shares shall be made in the amount of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the amount paid up on the relevant shares; increased with

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. an amount equal to the dividend not yet declared calculated over the period up to and including the
day of repayment, such in the manner as determined in article 37, paragraph 2, sub e.

**<u>Shares, share certificates, share register.</u>**

**<u>Article 6.</u>**

6.1. Shares shall be in registered form.

6.2. Ordinary shares shall be available:

- in the form of an entry in the share register without issue of a share certificate; shares of this type are referred to in these articles of association as type I shares;

and - should the supervisory board so decide - in the form of an entry in the share register with issue of a certificate, which certificate shall consist of a main part without dividend coupon; shares of this type and share certificates of this type are referred to in these articles of association as type II shares.

Preference shares shall only be made available in the form of type I shares.

6.3. The supervisory board can decide that the registration of type I shares may only take place for one
or more quantities of shares - which quantities are to be specified by the supervisory board - at the same time.

![](image_001.jpg)

6.4. Type II share certificates shall be available in such denominations as the supervisory board shall
determine.

6.5. All share certificates shall be signed by or on behalf of a managing director; the signature may be
effected by printed facsimile. Furthermore type II share certificates shall, and all other share certificates may, be countersigned by
one or more persons designated by the managing board for that purpose.

6.6. All share certificates shall be identified by numbers and/or letters.

6.7. The supervisory board can determine that for the purpose of effecting trading or transfer of shares
at foreign exchanges share certificates shall be issued in such form as the supervisory board may determine, complying with the requirements
set by said foreign exchange(s) and not provided with any dividend sheet.

6.8. The expression "share certificate" as used in these articles of association shall include
a share certificate in respect of more than one share.

**<u>Article 7.</u>**

7.1. Upon written request from a shareholder, missing or damaged share certificates, or parts thereof, may
be replaced by new certificates or by duplicates bearing the same numbers and/or letters, provided the applicant proves his title and,
in so far as applicable, his loss to the satisfaction of the supervisory board, and further subject to such conditions as the managing
board may deem fit.

7.2. In appropriate cases, at its own discretion, the managing board may stipulate that the identifying
numbers and/or letters of missing documents be published three times, at intervals of at least one month, in at least three newspapers
to be indicated by the managing board announcing the application made; in such a case new certificates or duplicates may not be issued
until six months have expired since the last publication, always provided that the original documents have not been produced to the managing
board before that time.

7.3. The issue of new certificates or duplicates shall render the original document invalid.

**<u>Article 8.</u>**

8.1. Notwithstanding the statutory provisions in respect of registered shares a register shall be kept by
or on behalf of the company, which register shall be regularly updated and, at the discretion of the managing board, may, in whole or
in part, be kept in more than one copy and at more than one place.

A part of the register may be kept abroad in order to meet requirements set out by foreign statutory provisions or provisions of the foreign exchange.

8.2. Each shareholder's name, his address and such further data as the managing board deems desirable, whether
at the request of a shareholder or not, shall be entered in the register.

8.3. The form and the contents of the share register shall be determined by the managing board with due
regard to the provisions of paragraphs 1 and 2 of this article.

The managing board may determine that the records shall vary as to their form and contents according to whether they relate to type I shares or to type II shares.

8.4. Upon request a shareholder shall be given free of charge a declaration of what is stated in the register
with regard to the shares registered in his name, which declaration may be signed by one of the specially authorized persons to be appointed
by the managing board for this purpose.

![](image_001.jpg)

8.5. The provisions of the last four paragraphs shall equally apply to those who hold a right of usufruct
or of pledge on one or more registered shares, with the proviso that the other data required by law must be entered in the register.

**<u>Article 9.</u>**

9.1. Subject to the provisions of article 6, the holder of an entry in the share register for one or more
type I shares may, upon his request and at his option, have issued to him one or more type II share certificates for the same nominal
amount.

9.2. Subject to the provisions of article 6, the holder of a type II share certificate registered in his
name may, after lodging the share certificate with the company, upon his request and at his option, either have one or more type I shares
entered in the share register for the same nominal amount.

9.3. A request as mentioned in this article shall, if the supervisory board so requires, be made on a form
obtainable from the company free of charge, which shall be signed by the applicant.

**<u>Transfer of shares.</u>**

**<u>Article 10.</u>**

10.1. The transfer of a registered share shall be effected either by service upon the company of the instrument
of transfer or by written acknowledgement of the transfer by the company, subject however to the provisions of the following paragraphs
of this article.

10.2. Where a transfer of a type II share is effected by service of an instrument of transfer on the company,
the company shall, at the discretion of the managing board, either endorse the transfer on the share certificate or cancel the share certificate
and issue to the transferee one or more new share certificates registered in his name to the same nominal amount.

10.3. The company's written acknowledgement of a transfer of a type II share shall, at the discretion of
the managing board, be effected either by endorsement of the transfer on the share certificates or by the issue to the transferee of one
or more new share certificates registered in his name to the same nominal amount.

10.4. The provisions of the foregoing paragraphs of this article shall equally apply to the allotment of
registered shares in the event of a judicial partition of any community of property or interests, the transfer of a registered share as
a consequence of a judgment execution and the creation of limited rights in rem on a registered share.

If a share certificate has been issued, the acknowledgement can only be effected either by putting an endorsement to that effect on this document, signed by or on behalf of the company, or by replacing this document by a new certificate in the name of the acquirer.

10.5. The submission of requests and the lodging of documents referred to in articles 7 to 10 inclusive shall
be made at a place to be indicated by the managing board and in any case the places where the company is admitted to a stock exchange.

Different places may be indicated for the different classes and types of shares and share certificates.

10.6. The company is authorized to charge amounts to be determined by the managing board not exceeding cost
price to those persons who request any services to be carried out by virtue of articles 7 up to and including 10.

![](image_001.jpg)

**<u>Usufructuaries, pledgees, holders of depositary receipts.</u>**

**<u>Article 11.</u>**

11.1. The usufructuary, who in conformity with the provisions of section 88, Book 2, Dutch Civil Code has
no right to vote, and the pledgee who in conformity with the provisions of section 89, Book 2, Dutch Civil Code has no right to vote,
shall not be entitled to the rights which by law have been conferred on holders of depositary receipts for shares issued with the cooperation
of the company.

11.2. Where in these articles of association persons are mentioned, entitled to attend meetings of shareholders,
this shall include holders of depositary receipts for shares issued with the cooperation of the company and persons who in pursuance of
paragraph 4 in section 88 or section 89, Book 2, Dutch Civil Code have the rights that by law have been conferred on holders of depositary
receipts for shares issued with the cooperation of the company.

**<u>Managing board.</u>**

**<u>Article 12.</u>**

12.1. The company shall be managed by a managing board consisting of two or more managing directors, including
in any event one managing director carrying the title of Chief Executive Officer and one managing director carrying the title of Chief
Financial Officer, under the supervision of the supervisory board. The number of members of the managing board shall be resolved upon
by the supervisory board, with due observance of the preceding sentence. The members of the managing board shall be appointed for no more
than three years, a year being understood as meaning the period between two general meetings of shareholders in which the annual accounts
of the previous financial year are adopted.

12.2. Managing directors shall be appointed by the general meeting of shareholders upon the proposal of the
supervisory board for each vacancy to be filled.

12.3. Without prejudice to the provisions of article 28, paragraph 2, a proposal to appoint one or more managing
directors to the managing board may be placed on the agenda of a general meeting of shareholders by the supervisory board.

12.4. The company has a policy regarding the compensation of the managing board. The policy will be adopted
by the general meeting of shareholders upon the proposal of the supervisory board.

12.5. The supervisory board shall determine the compensation of the individual managing directors, within
the scope of the compensation policy referred to in the previous paragraph. The supervisory board will submit for approval by the general
meeting of shareholders a proposal regarding the compensation in the form of shares or rights to acquire shares. This proposal sets forth
at least how many shares or rights to acquire shares may be awarded to the managing board and which criteria apply to an award or a modification.

12.6. The general meeting of shareholders shall decide in accordance with the provisions of article 32, paragraph
1. 8

![](image_001.jpg)

Votes in respect of persons who have not been so nominated shall be invalid.

**<u>Article 13.</u>**

13.1. The general meeting of shareholders shall be entitled to suspend or dismiss one or more managing directors,
provided that at least half of the issued share capital is represented at the meeting. No such quorum shall be required where the suspension
or dismissal is proposed by the supervisory board.

13.2. Where a quorum under paragraph 1 is required but is not present, a further meeting shall be convened,
to be held within four weeks after the first meeting, which shall be entitled, irrespective of the share capital represented, to pass
a resolution in regard to the suspension or dismissal.

13.3. The managing directors can be jointly or individually suspended by the supervisory board. After suspension
a general meeting of shareholders shall be convened within three months, at which meeting it shall be decided whether the suspension shall
be cancelled or maintained.

The person involved shall be given the opportunity to account for his actions at that meeting.

**<u>Representation.</u>**

**<u>Article 14.</u>**

14.1. The entire managing board as well as each managing director may represent the company.

14.2. The managing board may grant powers of attorney to persons, whether or not in the service of the company,
to represent the company and shall thereby determine the scope of such powers of attorney and the titles of such persons.

14.3. The managing board shall have power to perform legal acts as specified in section 94, paragraph 1,
Book 2, Dutch Civil Code in so far as such power is not expressly excluded or limited by any provision of these articles of association
or by any resolution of the supervisory board.

**<u>Article 15.</u>**

15.1. The supervisory board shall appoint one of the managing directors as chairman of the managing board.
The person so appointed shall also carry the title of Chief Executive Officer. The supervisory board shall also grant another managing
director the title of Chief Financial Officer. The supervisory board may also revoke these titles. These resolutions shall be passed with
the majority mentioned in article 22, paragraph 1.

15.2. Resolutions of the managing board shall be passed by simple majority of votes. In the event of a tie
of votes the chairman of the managing board shall have a casting vote.

**<u>Article 16.</u>**

16.1. Without prejudice to provisions made elsewhere in these articles of association, the managing board
shall require the prior express approval:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) from the supervisory board for decisions relating to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. all proposals to be submitted to a vote at the general meeting of shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. the formation of all companies, acquisition or sale of any participation, and conclusion of any cooperation
and participation agreement;

![](image_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. all pluri-annual plans of the company and the budget for the first coming year, covering the following
matters:

- investment policy;

- policy regarding research and development, as well as commercial policy and objectives;

- general financial policy;

- policy regarding personnel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. all acts, decisions or operations covered by the above list and constituting a significant change with
respect to decisions already adopted by the supervisory board or not provided for in the above list and as specifically laid down by the
supervisory board by resolution passed by it to that effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) from the general meeting of shareholders with respect to resolutions: regarding a significant change
in the identity or nature of the company or the enterprise, including in any event (a) transferring the enterprise or practically the
entire enterprise to a third party, (b) entering into or cancelling any long-term cooperation between the company or a subsidiary ()"*dochtermaatschappij* ")
and any other legal person or company or as a fully liable general partner of a limited partnership or a general partnership, provided
that such cooperation or the cancellation thereof is of essential importance to the company, and (c) the company or a subsidiary (*dochtermaatschappij*)
acquiring or disposing of a participating interest in the capital of a company with a value of at least one-third of the company's total
assets according to the consolidated balance sheet and notes thereto in the most recently adopted annual accounts of the company;

the absence of the approval provided for above may not be raised by or against third parties.

16.2. Without prejudice to provisions made elsewhere in these articles of association, the managing board
shall require the approval of the general meeting of shareholders according to the law and the provisions of these articles of association
as well as such resolutions as are clearly defined by a resolution of the general meeting of shareholders to that effect.

**<u>Article 17.</u>**

In the event of the absence or inability to act of one of more managing directors the remaining managing directors or managing director shall temporarily be responsible for the entire management. In the event of the absence or inability to act of all managing directors, one or more persons appointed by the supervisory board for this purpose at any time shall be temporarily responsible for the management.

**<u>Supervisory board.</u>**

**<u>Article 18.</u>**

18.1. The supervisory board shall be responsible for supervising the policy pursued by the managing board
and the general course of affairs of the company and the business enterprise which it operates.

![](image_001.jpg)

The supervisory board shall assist the managing board with advice relating to the general policy aspects connected with the activities of the company. In fulfilling their duties the supervisory directors shall serve the interests of the company and the business enterprise which it operates.

18.2. The managing board shall provide the supervisory board in good time with all relevant information as
well as the information the supervisory board requests, in connection with the exercise of its duties.

18.3. At least once per year the managing board shall inform the supervisory board in writing of the main
features of the strategic policy, the general and financial risks and the management and control systems of the company.

The managing board shall then submit to the supervisory board for approval:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) the operational and financial objectives of the company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) the strategy designed to achieve the objectives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) the parameters to be applied in relation to the strategy, inter alia, regarding financial ratios; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) corporate social responsibility issues that are relevant to the enterprise.

**<u>Article 19.</u>**

19.1. The supervisory board shall consist of at least six members, to be appointed by the general meeting
of shareholders upon the proposal of the supervisory board for each vacancy to be filled. The number of supervisory directors shall without
prejudice to the preceding sentence be resolved upon by the general meeting of shareholders upon the proposal of the supervisory board.

19.2. The general meeting of shareholders shall decide in accordance with the provisions of article 32, paragraph
1. 19.3. Without prejudice to the provisions of article 28, paragraph 2, a proposal to appoint one or more supervisory
directors to the supervisory board may be placed on the agenda of the general meeting of shareholders by the supervisory board.

19.4. The supervisory board shall appoint from among their midst a chairman and a vice-chairman of the supervisory
board with the majority mentioned in article 22, paragraph 1.

19.5. Upon the appointment of the supervisory directors the particulars as referred to in section 142, paragraph
3, Book 2, Dutch Civil Code shall be made available for prior inspection.

**<u>Article 20.</u>**

20.1. The supervisory board may appoint one or more of its members as delegate supervisory director in charge
of supervising the managing board on a regular basis. They shall report their findings to the supervisory board. The offices of chairman
of the supervisory board and delegate supervisory director are compatible.

20.2. With due observance of these articles of association, the supervisory board may adopt rules regulating
the division of its duties among its various supervisory directors.

![](image_001.jpg)

The supervisory board may also delegate certain of its powers to committees which exclusively consist of members of the supervisory board, such as an audit committee, a compensation committee or any other committee as the supervisory board may resolve to install. In case the authority to resolve upon the issuance of new shares is delegated to the supervisory board, the supervisory board may install a pricing committee which shall exclusively consist of members of the supervisory board and which shall be authorized within the range set in the delegation mentioned above to determine on behalf of the supervisory board the price and conditions for newly issued shares.

20.3. The supervisory board may decide that one or more of its members shall have access to all premises
of the company and shall be authorized to examine all books, correspondence and other records and to be fully informed of all actions
which have taken place, or may decide that one or more of its supervisory directors shall be authorized to exercise a portion of such
powers.

20.4. At the expense of the company, the supervisory board may obtain such advice from experts as the supervisory
board deems desirable for the proper fulfilment of its duties.

**<u>Article 21.</u>**

21.1. A supervisory director shall retire no later than at the first ordinary general meeting of shareholders
held after a period of three years following his appointment.

A retired supervisory director may immediately be re-elected.

21.2. The supervisory board may establish a rotation scheme.

21.3. The supervisory directors may be suspended or dismissed by the general meeting of shareholders. The
supervisory board may make a proposal to the general meeting of shareholders for the suspension or dismissal of one or more of its supervisory
directors.

21.4. In the event of the absence or inability to act of one of more supervisory directors the remaining
supervisory directors or supervisory director shall temporarily be responsible for the entire supervision. In the event of the absence
or inability to act of all supervisory directors, one or more persons appointed by the general meeting of shareholders for this purpose
at any time shall be temporarily responsible for the supervision.

**<u>Article 22.</u>**

22.1. The supervisory board may pass resolutions by at least three quarters of the votes of the members in
office. Each supervisory director has the right to cast one vote. In case of absence a supervisory director may issue a proxy, however,
only to another supervisory director. The proxy should explicitly indicate in which way the vote must be cast. The supervisory board may
pass resolutions in writing without holding a meeting provided that the proposals for such resolutions have been communicated in writing
to all supervisory directors and no supervisory director is opposed to this method of passing a resolution.

22.2. A certificate signed by two supervisory directors to the effect that the supervisory board has passed
a particular resolution shall constitute evidence of such a resolution in dealings with third parties.

22.3. The managing directors shall attend meetings of the supervisory board at the latter's request.

22.4. The supervisory board shall meet whenever two or more of its members or the managing board so requests.
Meetings of the supervisory board shall be convened by the chairman of the supervisory board, either on request of two or more supervisory
directors or on request of the managing board, or by the supervisory directors requesting the meeting to be held. If the chairman fails
to convene a meeting to be held within four weeks of the receipt of the request, the supervisory board members making the request are
entitled to convene the meeting.

![](image_001.jpg)

22.5. The supervisory board shall draw up standing orders regulating inter alia the manner of convening board
meetings and the internal procedure at such meetings. These meetings may be held by telephone as well as by video.

**<u>Article 23.</u>**

The general meeting of shareholders determines the compensation of the members of the supervisory board or of one or more of its members. The meeting shall have authority to decide whether such compensation will consist of a fixed amount and/or an amount that is variable in proportion to profits or any other factor. The supervisory board members shall be reimbursed for their expenses.

**<u>Indemnification.</u>**

**<u>Article 24.</u>**

24.1. The company shall indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than
an action by or in the right of the company) by reason of the fact that he is or was a supervisory director, managing director, officer
or agent of the company, or was serving at the request of the company as a supervisory director, managing director, officer or agent of
another company, a partnership, joint venture, trust or other enterprise, against all expenses (including attorneys' fees) judgments,
fines and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he
acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the company, and, with respect
to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful or out of his mandate. The termination
of any action, suit or proceeding by a judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall
not, of itself, create a presumption that the person did not act in good faith and not in a manner which he reasonably believed to be
in or not opposed to the best interests of the company, and, with respect to any criminal action or proceeding, had reasonable cause to
believe that his conduct was unlawful.

24.2. The company shall indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or proceeding by or in the right of the company to procure a judgment in its favor, by reason
of the fact that he is or was a supervisory director, managing director, officer or agent of the company, or is or was serving at the
request of the company as a supervisory director, managing director, officer or agent of another company, a partnership, joint venture,
trust or other enterprise, against expenses (including attorneys' fees) actually and reasonably incurred by him in connection with the
defense or settlement of such action or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed
to the best interests of the company and except that no indemnification shall be made in respect of any claim, issue or matter as to which
such person shall have been adjudged to be liable for gross negligence or wilful misconduct in the performance of his duty to the company,
unless and only to the extent that the court in which such action or proceeding was brought or any other court having appropriate jurisdiction
shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person
is fairly and reasonably entitled to indemnification against such expenses which the court in which such action or proceeding was brought
or such other court having appropriate jurisdiction shall deem proper.

![](image_001.jpg)

24.3. To the extent that a supervisory director, managing director, officer or agent of the company has been
successful on the merits or otherwise in defense of any action, suit of proceeding, referred to in paragraphs 1 and 2, or in defense of
any claim, issue or matter therein, he shall be indemnified against expenses (including attorney's fees) actually and reasonable incurred
by him in connection therewith.

24.4. Any indemnification by the company referred to in paragraphs 1 and 2 shall (unless ordered by a court)
only be made upon a determination that indemnification of the supervisory director, managing director, officer or agent is proper in the
circumstances because he had met the applicable standard of conduct set forth in paragraphs 1 and 2. Such determination shall be made:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. either by the supervisory board by a majority vote in a meeting in which a quorum as mentioned in article
22, paragraph 1, and consisting of supervisory directors who were not parties to such action, suit or proceeding, is present;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. or, if such a quorum is not obtainable or although such a quorum is obtained if the majority passes
a resolution to that effect, by independent legal counsel in a written opinion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. or by the general meeting of shareholders.

24.5. Expenses incurred in defending a civil or criminal action, suit or proceeding may be paid by the company
in advance of the final disposition of such action, suit or proceeding upon a resolution of the supervisory board with respect to the
specific case upon receipt of an undertaking by or on behalf of the supervisory director, managing director, officer or agent to repay
such amount unless it shall ultimately be determined that he is entitled to be indemnified by the company as authorized in this article.

24.6. The indemnification provided for by this article shall not be deemed exclusive of any other right to
which a person seeking indemnification may be entitled under any by-laws, agreement, resolution of the general meeting of shareholders
or of the disinterested supervisory directors or otherwise, both as to actions in his official capacity and as to actions in another capacity
while holding such position, and shall continue as to a person who has ceased to be a supervisory director, managing director, officer
or agent and shall also inure to the benefit of the heirs, executors and administrators of such a person.

24.7. The company shall have the power to purchase and maintain insurance on behalf of any person who is
or was a supervisory director, managing director, officer or agent of the company, or is or was serving at the request of the company
as a supervisory director, managing director, officer, employee or agent of another company, a partnership, joint venture, trust or other
enterprise, against any liability asserted against him and incurred by him in any such capacity or arising out of his capacity as such,
whether or not the company would have the power to indemnify him against such liability under the provisions of this article.

![](image_001.jpg)

24.8. Whenever in this article reference is being made to the company, this shall include, in addition to
the resulting or surviving company also any constituent company (including any constituent company of a constituent company) absorbed
in a consolidation or merger which, if its separate existence had continued, would have had the power to indemnify its supervisory directors,
managing directors, officers and agents, so that any person who is or was a supervisory director, managing director, officer or agent
of such constituent company, or is or was serving at the request of such constituent company as a supervisory director, managing director,
officer or agent of another company, a partnership, joint venture, trust or other enterprise, shall stand in the same position under the
provisions of this article with respect to the resulting or surviving company as he would have with respect to such constituent company
if its separate existence had continued.

**<u>General meeting of shareholders.</u>**

**<u>Article 25.</u>**

25.1. The ordinary general meeting of shareholders shall be held each year within six months after the close
of the financial year.

25.2. At this general meeting of shareholders shall be dealt with:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the written report of the managing board on the course of business of the company and the conduct of
its affairs during the past financial year, and the report of the supervisory board on the annual accounts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. adoption of the annual accounts and the declaration of dividend in the manner laid down in article
37;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. granting of discharge to the managing directors for their management during the past financial year
and to the members of the supervisory board for their supervision on such management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. filling vacancies in the managing board in accordance with the provisions of article 12;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. filling vacancies in the supervisory board in accordance with the provisions of article 19;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. the proposals placed on the agenda by the managing board or by the supervisory board, together with
proposals made by shareholders in accordance with the provisions of these articles of association.

**<u>Article 26.</u>**

26.1. Extraordinary general meetings of shareholders shall be held as often as deemed necessary by the supervisory
board and shall be held if one or more shareholders and other persons entitled to attend the meetings of shareholders jointly representing
at least one-tenth of the issued share capital make a written request to that effect to the managing board or supervisory board, specifying
in detail the business to be dealt with.

26.2. If the managing board or supervisory board fail to comply with a request under paragraph 1 above in
such manner that the general meeting of shareholders can be held within six weeks after the request, the persons making the request may
be authorized by the President of the Court within whose jurisdiction the company is established to convene the meeting themselves.

![](image_001.jpg)

26.3. Written requests as referred to in paragraph 1 of this article, section 110, subsection 1, Book 2,
Dutch Civil Code and article 28 paragraphs 2 and 3 may not be submitted electronically. Requests as referred to in paragraph 1 of this
article, article 28 paragraphs 2 and 3 and section 110, subsection 1, Book 2, Dutch Civil Code shall comply with conditions stipulated
by the managing board, subject to the approval of the supervisory board, which conditions shall be posted on the company's website.

**<u>Article 27.</u>**

27.1. General meetings of shareholders shall be held in Amsterdam, Haarlemmermeer (Schiphol Airport), Rotterdam
or The Hague; the notice convening the meeting shall inform the shareholders and other persons entitled to attend the meetings of shareholders
accordingly.

27.2. Notice of general meetings of shareholders shall be given by the managing board or by the supervisory
board or by those who according to the law or these articles of association are entitled thereto. The notice shall be given in such manner
as shall be authorized or required by law (including but not limited to a written notice, a legible and reproducible message sent by electronic
means and an announcement published by electronic means), as well as in accordance with the regulations of a stock exchange where the
shares in the company's share capital are officially listed at the company's request. In addition, shareholders and other persons
entitled to attend the meetings of shareholders which are registered in the share register of the company shall be notified by letter
that the meeting is being convened.

**<u>Article 28.</u>**

28.1. The notice convening the meeting referred to in the foregoing shall be given with due observance of
the statutory notice period.

28.2. The agenda shall contain such business as may be placed thereon by the person(s) entitled to convene
the meeting, and furthermore such business as one or more shareholders, representing at least one-tenth of the issued share capital, have
requested the managing board or supervisory board to place on the agenda at least five days before the date on which the meeting is convened.
Nominations for appointment to the managing board and the supervisory board cannot be placed on the agenda by the managing board. No resolution
shall be passed at the meeting in respect of matters not on the agenda.

28.3. Notwithstanding paragraph 2, proposals of persons who are entitled to attend the meetings of shareholders
will be included in the agenda, if such proposal is made in writing to the managing board within a period of sixty days before that meeting
by persons who are entitled to attend the meetings of shareholders, who solely or jointly, represent at least one per cent (1%) of the
company's issued share capital or a market value of at least fifty million euro (EUR 50,000,000), unless the company determines that such
proposal would conflict with substantial interests of the company.

28.4. The notice shall state the business to be transacted as well as the other information prescribed by
law and these articles of association.

![](image_001.jpg)

**<u>Article 29.</u>**

29.1. General meetings of shareholders shall be presided over by the chairman of the supervisory board or
in his absence by the vice-chairman of the supervisory board. In case of absence of the chairman and the vice- chairman of the supervisory
board the meeting shall be presided by any other person nominated by the supervisory board.

29.2. Minutes shall be kept of the business transacted at a general meeting of shareholders, which minutes
shall be drawn up and signed by the chairman and by a person appointed by him immediately after the opening of the meeting.

29.3. Where the minutes are drawn up before a civil-law notary, the chairman's signature, together with that
of the civil-law notary, shall be sufficient.

**<u>Article 30.</u>**

30.1. All shareholders and other persons entitled to attend the meetings of shareholders are entitled to
attend the general meetings of shareholders, to address the general meeting of shareholders and, if applicable, to vote.

Subject to the approval of the supervisory board, the managing board may resolve that holders of shares and other persons entitled to attend the meetings of shareholders are authorized to directly take note of the business transacted at the meeting via an electronic means of communication.

The general meeting of shareholders may lay down rules regulating, inter alia, the length of time for which shareholders may speak. In so far as such rules are not applicable, the chairman may regulate the time for which shareholders may speak if he considers this to be desirable with a view to the orderly conduct of the meeting.

30.2. Only if the law does not prescribe a fixed record date, the managing board shall, with due observance
of the relevant statutory provisions, determine a record date for the general meeting of shareholders. Persons entitled to attend the
meetings of shareholders are those who at the record date have these rights and have been registered as such in a register designated
by the managing board for that purpose, regardless of who would have been entitled to attend the general meeting of shareholders if a
record date as contemplated in this paragraph had not been determined. The convocation notice for the meeting shall state the record date
and the manner in which the persons entitled to attend the meetings of shareholders may register and exercise their rights.

30.3. The managing board may, subject to the approval of the supervisory board, decide that persons entitled
to attend the meetings of shareholders and vote thereat may, within a period prior to the general meeting of shareholders to be set by
the managing board, which period cannot start prior to the record date as meant in the previous paragraph, cast their votes electronically
in a manner to be decided by the managing board and/or by post. Votes cast in accordance with the previous sentence equal votes cast at
the meeting.

**<u>Article 31.</u>**

31.1. Shareholders and other persons entitled to attend the meetings of shareholders may be represented by
proxies with written authority. If the meeting rights are exercised in accordance with article 30, paragraph 2, by a person authorized
in writing, the proxy with written authority must be received by the person designated by the corporate body convening the general meeting
of shareholders no later than at the date as mentioned in the notice convening the meeting.

![](image_001.jpg)

31.2. All matters regarding the admittance to the general meeting of shareholders, the exercise of voting
rights and the result of votings, as well as any other matters regarding the affairs at the general meeting of shareholders shall be decided
upon by the chairman of that meeting, with due observance of the provisions of section 13, Book 2, Dutch Civil Code.

**<u>Article 32.</u>**

32.1. Unless otherwise stated in these articles, resolutions shall be adopted by simple majority of votes
of the shareholders having the right to vote in a meeting of shareholders where at least fifteen per cent of the issued capital is present
or represented. Blank and invalid votes shall not be counted. The chairman shall decide on the method of voting and on the possibility
of voting by acclamation.

32.2. Where the voting concerns appointments, further polls shall, if necessary, be taken until one of the
nominees has obtained a simple majority, such with due observance of the provision of paragraph 1 of this article. The further poll or
polls may, at the chairman's discretion, be taken at a subsequent meeting.

32.3. Except as provided in paragraph 2, in case of an equality of the votes cast the relevant proposal shall
be deemed to have been rejected.

**<u>Article 33.</u>**

33.1. At the general meeting of shareholders each share shall confer the right to cast one vote.

33.2. The managing board may, subject to the approval of the supervisory board, resolve that each person
entitled to attend and vote at the meetings of shareholders is authorized to vote via an electronic means of communication, either in
person or by a person authorized in writing, provided that such person can be identified via the electronic means of communication and
furthermore provided that such person can directly take note of the business transacted at the meeting. The managing board may, subject
to the approval of the supervisory board, attach conditions to the use of the electronic means of communication, which conditions shall
be announced in the notice convening the general meeting of shareholders and shall posted on the company's website.

**<u>Meetings of holders of shares of a particular class.</u>**

**<u>Article 34.</u>**

34.1. A meeting of holders of preference shares shall be held whenever required by virtue of the provisions
of these articles of association and further whenever the managing board and/or the supervisory board shall decide, and also whenever
one or more holders of preference shares so request the managing board and/or the supervisory board in writing, stating the items of business
to be transacted.

If after receipt of a request as referred to in the preceding sentence neither the managing board nor the supervisory board has called a meeting in such a way that the meeting is held within four weeks of receipt, the applicant(s) shall be authorized to call the meeting themselves, with due observance of the relevant provisions of these articles of association.

34.2. The managing directors and the supervisory directors shall have the right to attend meetings of holders
of preference shares; in that capacity they shall have an advisory vote. Notice of a meeting of holders of preference shares shall be
given by letters sent to all holders of preference shares. The notice shall state the items of business to be transacted.

![](image_001.jpg)

34.3. Articles 27 up to and including 33 shall apply accordingly to meetings of holders of preference shares,
with the proviso that the notice convening such a meeting shall only take place by letter or - if the relevant person entitled to attend
such meeting so agrees - via a legible and reproducible message sent by electronic mail to the address notified for this purpose to the
company by the relevant person entitled to attend such meetings.

34.4. At a meeting of holders of preference shares at which the entire issued capital in shares of that class
is represented, valid resolutions may be adopted, provided that they are passed by unanimous vote, even if the requirements in respect
of the place of the meeting, the manner of notice, the term of notice and the stating in the notice of the items of business to be transacted,
have not been observed.

34.5. All resolutions which may be adopted by the holders of preference shares at a meeting may also be adopted
outside a meeting.

Resolutions may be adopted outside a meeting only if all holders of preference shares and other persons entitled to vote on preference shares have declared themselves in favor of the proposal by letter or telecopier. The resolution shall be recorded in the minute book of the meeting of holders of preference shares by a managing director.

34.6. The managing board may, subject to the approval of the supervisory board, resolve that written resolutions
as referred to in the preceding paragraph of this article may be adopted via an electronic means of communication. The managing board
may, subject to the approval of the supervisory board, attach conditions to the use of the electronic means of communication, which conditions
shall be notified in writing to all holders of preference shares and other persons entitled to vote on preference shares.

34.7. A meeting of holders of ordinary shares shall be held whenever required by virtue of the provisions
of these articles of association. Articles 27 up to and including 33 shall apply accordingly to meetings of holders of ordinary shares.

**<u>Annual accounts, annual report and distributions.</u>**

**<u>Article 35.</u>**

35.1. The financial year shall run from the first day of January up to and including the thirty-first day
of December.

35.2. Annually, within four months after the close of each financial year, the managing board shall draw
up the annual accounts. Within this period the managing board shall also draw up the annual report.

**<u>Article 36.</u>**

36.1. The supervisory board shall cause the annual accounts to be examined by one or more registered accountant(s)
designated for the purposes by the general meeting of shareholders or other experts designated for the purpose in accordance with section
393, Book 2, Dutch Civil Code, and shall report to the general meeting of shareholders on the annual accounts, notwithstanding the provisions
of the law. The accountant, as referred to in this paragraph, is authorized to attend the general meeting of shareholders in which a resolution
about the adoption of the annual accounts shall be adopted and to address that meeting.

![](image_001.jpg)

36.2. Annually, no later than four months after the close of the financial year the managing board, in accordance
with the statutory obligations to which the company is subject, shall make generally available: (i) the annual accounts, (ii) the annual
report, (iii) the accountant's statement as referred to in paragraph 1 of this article, as well as (iv) other information which, under
or pursuant to the law, must be made generally available together with the annual accounts.

**<u>Profit and loss.</u>**

**<u>Article 37.</u>**

37.1. Distribution of profits pursuant to this article shall be made following approval of the annual accounts
which show that the distribution is permitted.

The company may only make distributions to shareholders and other persons entitled to distributable profits to the extent that its equity exceeds the total amount of its issued capital and the reserves which must be maintained by law.

A deficit may only be offset against the reserves prescribed by law in so far as permitted by law.

37.2. a. From the profits shall first, if possible, be distributed on the preference shares the percentage as specified hereinafter under b below of the
compulsory amount paid up or to be paid up on these shares as at the commencement of the financial year for which the distribution is
made or - if the shares are issued during that financial year - as at the day on which such shares are issued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. The percentage as referred to above under a shall be equal to Euribor (Euro Interbank Offered Rate)
for deposit loans with a term of one year, established per the day which is two bank business days prior to the day of the first issue
of the preference shares, such at eleven o'clock ante meridiem Central European Time, increased with a rise of maximum one hundred and
fifty basis points, determined by the managing board, subject to the approval of the supervisory board.<br>
If in the course of the financial year for which the distribution is made the compulsory amount to be paid on the preference shares has
been decreased or, pursuant to a resolution for additional payments, increased, then the distribution shall be decreased or, if possible,
increased by an amount equal to the aforementioned percentage of the amount of the decrease or increase as the case may be, calculated
from the date of the decrease or from the day when the additional payment became compulsory, as the case may be.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. If and to the extent that the profits are not sufficient to make the distribution as referred to in
this article in full, the deficit shall be distributed from the reserves to the extent by doing so paragraph 1 of this article is not
contravened.

If and to the extent the distribution as referred to in the first sentence of this paragraph also cannot be made out of the reserves, then out of the profits realized in the following years first such a distribution shall be made to the holders of preference shares to make good for the entire deficit before the provisions of the following paragraphs shall apply.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. No further distributions shall be made on the preference shares then as determined in this article
and article 39.

![](image_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. If the profits for a financial year are being determined and if in that financial year one or more
preference shares have been cancelled with repayment, the persons who according to the shareholders' register as referred to in
article 8 at the time of such cancellation were recorded as the holders of these preference shares, shall have an inalienable right to
a distribution of profit as described hereinafter. The profits which, if sufficient, shall be distributed to such a person shall be equal
to the amount of the distribution to which he would be entitled pursuant to the provisions of this paragraph if at the time of the determination
of the profits he had still been the holder of the preference shares as referred to above, calculated on a time-proportionate basis for
the period during which he held preference shares in that financial year, which distribution shall be decreased with the amount of the
distribution which is made on the preference shares in accordance with article 39 paragraph 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. If in the course of any financial year preference shares have been issued, the dividend on preference
shares for that financial year shall be decreased time-proportionately calculated over the period that the relevant preference shares
were not issued.

37.3. Upon proposal of the managing board, the supervisory board shall determine what portion of the remaining
profits shall be retained by way of reserve.

37.4. The portion of the profits that remains after application of paragraph 2 and paragraph 3, shall be
at the disposal of the general meeting of shareholders, with due observance of the provisions of article 38, paragraph 2.

37.5. The general meeting of shareholders is empowered either to distribute the profits in cash or in kind
or to withhold distribution of the said portion of the profit in whole or in part.

**<u>Article 38.</u>**

38.1. The supervisory board independently and the general meeting of shareholders upon the proposal of the
supervisory board shall each be entitled to resolve to make distributions charged to the share premium reserve or charged to the other
reserves shown in the annual accounts not prescribed by the law, with due observance of the provisions of paragraph 2 of this article
and section 105, paragraph 4, Book 2, Dutch Civil Code, provided that the balance of the relevant reserve is not required to make the
distribution as referred to in article 37, paragraph 2, sub c, first sentence in conjunction with article 37, paragraph 2, sub a.

38.2. The supervisory board shall be entitled to resolve that distributions, the amount of which distributions
has been resolved upon by the general meeting of shareholders, to holders of shares under article 37, article 38, paragraph 1 and article
39, paragraph 1 may be made in full or partially in the form of the issue of shares in the share capital of the company. The distribution
to a shareholder according to the preceding sentence shall be made to a shareholder in cash or in the form of ordinary shares in the share
capital of the company, or partially in cash and partially in the form of shares in the share capital of the company, such, if the supervisory
board so resolves, at the option of the relevant shareholder.

![](image_001.jpg)

**<u>Article 39.</u>**

39.1. At its own discretion and subject to section 105, paragraph 4, Book 2, Dutch Civil Code, the supervisory
board may resolve to distribute one or more interim distributions on the shares before the annual accounts for any financial year have
been adopted at a general meeting of shareholders.

Interim distributions may also be made on either preference shares or ordinary shares.

39.2. In case of a cancellation of preference shares with repayment a distribution on the cancelled shares
shall be made on the day of repayment, which distribution shall be calculated in accordance with the provisions of article 37 and over
the period up to the day of repayment, such in accordance with section 105, paragraph 4, Book 2, Dutch Civil Code.

**<u>Article 40.</u>**

40.1. Distributions under articles 37, 38 or 39 shall be payable as from a date to be determined by the supervisory
board. The date of payment set in respect of shares for which certificates are outstanding or in respect of type I shares may differ from
the date of payment set in respect of shares for which type II share certificates are outstanding.

40.2. Distributions under articles 37, 38 or 39 shall be made payable at a place or places, to be determined
by the supervisory board; at least one place shall be designated thereto in the Netherlands.

40.3. The supervisory board may determine the method of payment in respect of cash distributions on type
I shares.

40.4. Cash distributions under articles 37, 38 or 39 in respect of shares for which a type II share certificate
is outstanding shall, if such distributions are made payable only outside the Netherlands, be paid in the currency of a country where
the shares of the company are listed on a stock exchange not being the Euro, converted at the rate of exchange determined by the European
Central Bank at the close of business on a day to be fixed for that purpose by the supervisory board. If and in so far as on the first
day on which a distribution is payable, the company is unable, in consequence of any governmental action or other exceptional circumstances
beyond its control, to make payment at the place designated outside the Netherlands or in the relevant currency, the supervisory board
may in that event designate one or more places in the Netherlands instead. In such event the provisions of the first sentence of this
paragraph shall no longer apply.

40.5. The person entitled to a distribution under articles 37, 38 or 39 on registered shares shall be the
person in whose name the share is registered at the date to be fixed for that purpose by the supervisory board in respect of each distribution
for the different types of shares.

40.6. The provisions of article 27 paragraph 2 shall apply accordingly to the notice of distributions and
of the dates and places as referred to in the preceding paragraphs of this article.

40.7. Distributions in cash under articles 37, 38 or 39 that have not been collected within five years after
they have become due and payable shall revert to the Company.

![](image_001.jpg)

40.8. In the case of a distribution under article 38, paragraph 2, any shares in the company not claimed
within a period to be determined by the supervisory board shall be sold for the account of the persons entitled to the distribution who
failed to claim the shares. The period and manner of sale to be determined by the supervisory board, as mentioned in the preceding sentence,
shall be notified according to paragraph 6. The net proceeds of such sale shall thereafter be held at the disposal of the above persons
in proportion to their entitlement; distributions that have not been collected within five years after the initial distributions in shares
have become due and payable shall revert to the company.

40.9. In the case of a distribution in the form of shares in the company under article 38, paragraph 2, on
registered shares, those shares shall be added to the share register. A type II share certificate for a nominal amount equal to the number
of shares added to the register shall be issued to holders of type II shares.

40.10. The provisions of paragraphs 5 and 6 shall apply equally in respect of distributions - including pre-emptive
subscription rights in the event of a share issue - made otherwise than under articles 37, 38 or 39.

**<u>Amendments to the articles of association, winding up, liquidation.</u>**

**<u>Article 41.</u>**

41.1. A resolution to alter the articles of association or to wind up the company shall be valid only provided
that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the proposal to such a resolution has been proposed to the general meeting of shareholders by the supervisory
board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the full proposals have been deposited for inspection by shareholders and other persons entitled to
attend meetings of shareholders, at the office of the company as from the day on which the notice is served until the close of that meeting.

41.2. A resolution to amend the articles of association by which the rights conferred on holders of shares
of a specific class as such are changed shall require the approval of the relevant class meeting.

**<u>Article 42.</u>**

42.1. If the company is wound up, the liquidation shall be carried out by any person designated for that
purpose by the general meeting of shareholders, under the supervision of the supervisory board.

42.2. In passing a resolution to wind up the company, the general meeting of shareholders shall upon the
proposal of the supervisory board fix the remuneration payable to the liquidators and to those responsible for supervising the liquidation.

42.3. The liquidation shall take place with due observance of the provisions of the law. During the liquidation
period these articles of association shall, to the extent possible, remain in full force and effect.

42.4. After settling the liquidation, the liquidators shall render account in accordance with the provisions
of the law.

42.5. After the liquidation has ended, the books and records of the company shall remain in the custody of
the person designated for that purpose by the liquidators during a seven-year period.

![](image_001.jpg)

**<u>Article 43.</u>**

From what is left of the company's assets after all debts have been settled, including any debts incurred in connection with the liquidation, first, if possible, all holders of preference shares shall have returned to them the paid up part of the nominal amount of their preference shares, increased with the missing dividend on the relevant preference shares at the time of liquidation calculated over the period up to and including the day on which the balance is made payable.

The residue shall be divided amongst the holders of ordinary shares pro rata to the par value of their respective holdings of ordinary shares.

**<u>Article 44.</u>**

Any amounts payable to shareholders or due to creditors which have not been claimed within six months after the last distribution was made payable, shall be deposited with the Public Administrator of Unclaimed Debts (*consignatiekas*).

**FINAL STATEMENTS**

Finally, the person appearing declared, as evidenced by the explanatory notes to the agenda relating to the general meeting of the Company held on the date hereof, to have been authorised to execute this Deed.

The person appearing is known to me, civil law notary.

This deed was executed in Amsterdam on the date mentioned in its heading.

After I, civil law notary, had conveyed and explained the contents of the deed in substance to the person appearing, the person appearing declared to have taken note of the contents of the deed, to be in agreement with these contents and not to wish the deed to be read out in full.

Following a partial reading, the deed was signed by the person appearing and by me, civil law notary.

(signatures follow)

**ISSUED FOR TRUE COPY**<br> (Signed: P.C.S. van der Bijl)<br>

## Exhibit 5.1

---

| | |
|:---|:---|
| ATTORNEYS • CIVIL LAW NOTARIES • TAX ADVISERS | ![](image_001.jpg) |
| Beethovenstraat 400<br> 1082 PR Amsterdam<br> T +31 20 71 71 000 | Amsterdam, 25 March 2026 |
|  | STMicroelectronics N.V. |

---

To the Dutch Company:

We have acted as legal counsel as to Dutch law to the Dutch Company in connection with the filing of the Registration Statement with the SEC. This opinion letter is rendered to you in order to be filed with the SEC as an exhibit to the Registration Statement.

Capitalised terms used in this opinion letter have the meanings set forth in Exhibit A. The headings used in this opinion letter are for convenience of reference only and are not to affect its construction or to be taken into consideration in its interpretation.

This opinion letter is strictly limited to the matters stated in it and may not be read as extending by implication to any matters not specifically referred to in it. Nothing in this opinion letter should be taken as expressing an opinion in respect of any representations or warranties, or other information, contained in any document reviewed by us in connection with this opinion letter.

In rendering the opinions expressed in this opinion letter, we have reviewed and relied upon the Warrant Agreement, a draft of the Registration Statement and pdf copies or drafts, as the case may be, of the Corporate Documents and we have assumed that the Warrant Agreement has been entered into for bona fide commercial reasons. We have not investigated or verified any factual matter disclosed to us in the course of our review.

This opinion letter sets out our opinion on certain matters of the laws with general applicability of the Netherlands, and, insofar as they are directly applicable in the Netherlands, of the European Union, as at today's date and as presently interpreted under published authoritative case law of the Dutch courts, the General Court and the Court of Justice of the European Union. We do not express any opinion on tax law, regulatory law, Dutch or European competition law, data protection law or securitization law. No undertaking is assumed on our part to revise, update or amend this opinion letter in connection with or to notify or inform you of, any developments and/or changes of Dutch law subsequent to today's date. We do not purport to opine on the consequences of amendments to the Warrant Agreement, the Registration Statement or the Corporate Documents subsequent to the date of this opinion letter.

All legal relationships are subject to NautaDutilh N.V.'s general terms and conditions (see <u>https://www.nautadutilh.com/terms</u>), which apply mutatis mutandis to our relationship with third parties relying on statements of NautaDutilh N.V., include a limi-tation of liability clause, have been filed with the Rotterdam District Court and will be provided free of charge upon request. NautaDutilh N.V.; corporate seat Rotterdam; trade register no. 24338323.

Amsterdam • Brussels • London • Luxembourg • New York • Rotterdam

![](image_001.jpg)

The opinions expressed in this opinion letter are to be construed and interpreted in accordance with Dutch law. The competent courts at Amsterdam, the Netherlands have exclusive jurisdiction to settle any issues of interpretation or liability arising out of or in connection with this opinion letter. Any legal relationship arising out of or in connection with this opinion letter (whether contractual or non-contractual), including the above agreement as to jurisdiction, is governed by Dutch law and shall be subject to the general terms and conditions of NautaDutilh. Any liability arising out of or in connection with this opinion letter shall be limited to the amount which is paid out under NautaDutilh's insurance policy in the matter concerned. No person other than NautaDutilh may be held liable in connection with this opinion letter.

In this opinion letter, legal concepts are expressed in English terms. The Dutch legal concepts concerned may not be identical in meaning to the concepts described by the English terms as they exist under the law of other jurisdictions. In the event of a conflict or inconsistency, the relevant expression shall be deemed to refer only to the Dutch legal concepts described by the English terms.

For the purposes of this opinion letter, we have assumed that:

***General Assumptions***

a. drafts of documents reviewed by us will be signed in the form of those drafts, each copy of a document conforms to the original, each original is authentic, and each signature is the genuine signature of the individual purported to have placed that signature;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the Deed of Incorporation and the Deed of Conversion are valid notarial deeds and the Deed of Incorporation
has been executed on the basis of a valid declaration of no objection (*verklaring van geen bezwaar*) and a valid bank statement
within the meaning of Article 2:203a DCC (as it applied on the date of the Deed of Incorporation);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. if any signature under any document is an electronic signature (as
opposed to a handwritten ("wet ink") signature) only, the method used for signing is sufficiently reliable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. the Registration Statement has been or will be declared effective
upon filing with the SEC in the form reviewed by us ;

***Corporate Law Assumptions***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. at each Relevant Moment, (i) Ordinary Shares shall have been admitted for trading on a trading system
outside the European Economic Area comparable to a regulated market or a multilateral trading facility as referred to in Article 2:86c(1)
DCC and (ii) no financial instruments issued by the Dutch Company (or depository receipts for or
otherwise representing such financial instruments) have been admitted to trading on a regulated market, multilateral trading facility
or organised trading facility operating in the European Economic Area (and no request for admission of any such financial instruments
to trading on any such trading venue has been made) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. (i) no regulations (*reglementen*) have been adopted by any corporate body of the Dutch Company other
than the Supervisory Board Charter and the Managing Board and Executive Committee Charter, (ii) the Articles of Association were the Dutch
Company's articles of association in force at the time the Warrant Agreement was executed, (iii) the Articles of Association are the Dutch
Company's articles of association currently in force and (vi) the Articles of Association will be the Dutch Company's articles of association
in force at each Relevant Moment. The Extract supports item (iii) of this assumption ;

![](image_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. (i) at each Relevant Moment, the resolutions recorded in the Resolutions shall be in full force and effect,
(ii) at each Relevant Moment, the factual statements made and the confirmations given in the Resolutions shall be complete and correct
and (iii) the Resolutions correctly reflect the resolutions recorded therein;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. at each Relevant Moment, the authorised share capital (*maatschappelijk kapitaal*) of the Dutch Company
shall allow for the issuance of the Warrant Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the exercise price for the Warrant shall at least equal the aggregate nominal value of the underlying
Warrant Shares, any such exercise price shall have been paid in cash or otherwise satisfied as provided for in the Warrant Agreement and
shall have been received and accepted by the Company ultimately upon the issuance of the relevant Warrant Shares and, where relevant,
the Company shall have consented to payment in a currency other than Euro;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. the Warrant (i) has been validly granted as a right to subscribe for Ordinary Shares (*recht tot het nemen van aandelen*), (ii) shall be in full force and effect upon being exercised and (iii) shall have been validly exercised in accordance
with the terms of the Warrant Agreement prior to the issuance of the underlying Warrant Shares; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. at each Relevant Moment, each of the other assumptions made in this opinion letter will be correct in
all aspects by reference to the facts and circumstances then existing.

Based upon and subject to the foregoing and subject to the qualifications set forth in this opinion letter and to any matters, documents or events not disclosed to us, we express the following opinions:

**Incorporation and Corporate Status**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Dutch Company has been duly incorporated as a *besloten vennootschap met beperkte aansprakelijkheid* and is validly existing as a *naamloze vennootschap*.

**Warrant Shares**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Subject to receipt by the Dutch Company of payment in full for, or other satisfaction of the exercise
price for, the Warrant Shares as provided for in the Warrant Agreement, and when issued and accepted in accordance with the Resolutions
and the Warrant Agreement, the Warrant Shares shall be validly issued, fully paid and non-assessable.

The opinions expressed above are subject to the following qualifications:

***Corporate Law Qualifications***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. The opinion expressed in paragraph 1 (*Incorporation and Corporate Status*) of this opinion letter
must not be read to imply that the Dutch Company cannot be dissolved (*ontbonden*). A company such as the Dutch Company may be dissolved, *inter alia* by the competent court at the request of the company's management board, any interested party (*belanghebbende*)
or the public prosecution office in certain circumstances, such as when there are certain defects in the incorporation of the company.
Any such dissolution will not have retro-active effect.

![](image_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. Pursuant to Article 2:7 DCC, any transaction entered into by a legal entity may be nullified by the legal
entity itself or its liquidator in bankruptcy proceedings (*curator*) if the objects of that entity were transgressed by the transaction
and the other party to the transaction knew or should have known this without independent investigation (*wist of zonder eigen onderzoek moest weten*). The Dutch Supreme Court (*Hoge Raad der Nederlanden*) has ruled that in determining whether the objects of a legal
entity are transgressed, not only the description of the objects in that legal entity's articles of association (*statuten*) is decisive,
but all (relevant) circumstances must be taken into account, in particular whether the interests of the legal entity were served by the
transaction. Based on the objects clause contained in the Current Articles, w e have no reason to
believe that, by entering into the Warrant Agreement, the Dutch Company would transgress the description of the objects contained in its
Articles of Association. However, we cannot assess whether there are other relevant circumstances that must be taken into account,
in particular whether the interests of the Dutch Company are served by entering into the Warrant
Agreement since this is a matter of fact.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. Pursuant to Article 2:98c DCC, a company such as the Dutch Company may grant loans (*leningen verstrekken*)
only in accordance with the restrictions set out in Article 2:98c DCC, and may not provide security (*zekerheid stellen*), give a
price guarantee (*koersgarantie geven*) or otherwise bind itself, whether jointly and severally or otherwise with or for third parties
(*zich op andere wijze sterk maken of zich hoofdelijk of anderszins naast of voor anderen verbinden*) with a view to (*met het oog op*) the subscription or acquisition by third parties of shares in its share capital or depository receipts. This prohibition also
applies to its subsidiaries (*dochtervennootschappen*). It is generally assumed that a transaction entered into in violation of Article
2:98c DCC is null and void (*nietig*). Based on the content of the Warrant Agreement ,
we have no reason to believe that the Dutch Company or its subsidiaries will violate Article 2:98c DCC in connection with the issue of
the Warrant Shares. However, we cannot confirm this definitively, since the determination of whether a company (or a subsidiary) has provided
security, has given a price guarantee or has otherwise bound itself, with a view to the subscription or acquisition by third parties of
shares in its share capital or depository receipts, as described above, is a matter of fact .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D. The opinions expressed in this opinion letter may be limited or affected by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. rules relating to Insolvency Proceedings or similar proceedings under a foreign law and other rules affecting
creditors' rights generally ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the provisions of fraudulent preference and fraudulent conveyance (*Actio Pauliana*) and similar
rights available in other jurisdictions to insolvency practitioners and insolvency office holders in bankruptcy proceedings or creditors ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. claims based on tort (*onrechtmatige daad*) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. sanctions and measures, including but not limited to those concerning export control, pursuant to European
Union regulations, under the Dutch Sanctions Act 1977 (*Sanctiewet 1977*) or other legislation ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. the Anti-Boycott Regulation, Anti-Money Laundering Laws and related legislation ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. any intervention, recovery or resolution measure by any regulatory or other authority or governmental
body in relation to financial enterprises or their affiliated entities; and

![](image_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. the rules of force majeure (*niet toerekenbare tekortkoming*), reasonableness and fairness (*redelijkheid en billijkheid*), suspension (*opschorting*), dissolution (*ontbinding*), unforeseen circumstances (*onvoorziene omstandigheden*)
and vitiated consent (i.e., duress (*bedreiging*), fraud (*bedrog*), abuse of circumstances (*misbruik van omstandigheden*)
and error (*dwaling*)) or a difference of intention (*wil*) and declaration (*verklaring*) .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E. The term "non-assessable" has no equivalent in the Dutch language and for purposes of this opinion
letter such term should be interpreted to mean that a holder of an Ordinary Share shall not by reason of merely being such a holder be
subject to assessment or calls by the Dutch Company or its creditors for further payment on such Ordinary Share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F. This opinion letter does not purport to express any opinion or view on the operational rules and procedures
of any clearing or settlement system or agency.

We consent to the filing of this opinion letter as an exhibit to the Registration Statement and also consent to the reference to NautaDutilh in the Registration Statement under the caption "Legal Matters". In giving this consent we do not admit or imply that we are a person whose consent is required under Section 7 of the United States Securities Act of 1933, as amended, or any rules and regulations promulgated thereunder.

![](image_001.jpg)

Sincerely yours,

/s/ Nauta Dutilh N.V.

NautaDutilh N.V.

![](image_001.jpg)

**EXHIBIT A**

**LIST OF DEFINITIONS**

---

| | |
|:---|:---|
| &nbsp;&nbsp;"**Anti-Boycott Regulation**" | &nbsp;&nbsp; Regulation (EC) No 2271/96 on protecting against the effects of the extra-territorial application of legislation adopted by a third country, and actions based thereon or resulting therefrom.<br>|
| &nbsp;&nbsp; "**Anti-Money Laundering Laws**"<br>| &nbsp;&nbsp; the European Anti-Money Laundering Directives, as implemented in the Netherlands in the Money Laundering and Terrorist Financing Prevention Act (*Wet ter voorkoming van witwassen en financieren van terrorisme*) and the Dutch Criminal Code (*Wetboek van Strafrecht*).<br>|
| &nbsp;&nbsp; "**Articles of Association**"<br>| &nbsp;&nbsp; the articles of association (*statuten*) of the Dutch Company as they read from time to time<br>|
| &nbsp;&nbsp; "**Commercial Register**"<br>| &nbsp;&nbsp; the Commercial Register held by the Dutch Chamber of Commerce (*handelsregister gehouden door de Kamer van Koophandel*)<br>|
| &nbsp;&nbsp; "**Corporate Documents**"<br>| &nbsp;&nbsp; the documents listed in Exhibit B<br>|
| &nbsp;&nbsp;"**Current Articles**" | &nbsp;&nbsp; the Articles of Association as contained in the deed of amendment dated 22 May 2024<br>|
| &nbsp;&nbsp; "**DCC**"<br>| &nbsp;&nbsp; the Dutch Civil Code (*Burgerlijk Wetboek*)<br>|
| &nbsp;&nbsp; "**Deed of Conversion**"<br>| &nbsp;&nbsp; the deed of conversion of the Dutch Company, dated 31 March 1989<br>|
| &nbsp;&nbsp; "**Deed of Incorporation**"<br>| &nbsp;&nbsp; the deed of incorporation (*akte van oprichting*) of the Dutch Company, dated 21 May 1987<br>|
| &nbsp;&nbsp; "**Dutch Company**"<br>| &nbsp;&nbsp; STMicroelectronics N.V.<br>|
| &nbsp;&nbsp; "**Dutch Bankruptcy Code**"<br>| &nbsp;&nbsp; the Dutch Bankruptcy Code (*Faillissementswet*)<br>|
| &nbsp;&nbsp; "**Exhibit**"<br>| &nbsp;&nbsp; an exhibit to this opinion letter<br>|
| &nbsp;&nbsp; "**Insolvency Proceedings**"<br>| &nbsp;&nbsp; any insolvency proceedings within the meaning of Regulation (EU) 2015/848 on insolvency proceedings (recast), listed in Annex A thereto, any statutory proceedings for the restructuring of debts (*akkoordprocedure*) pursuant to the Dutch Bankruptcy Code<br>|

---

![](image_001.jpg)

---

| | |
|:---|:---|
| &nbsp;&nbsp; "**Managing Board and Executive Committee Charter**"<br>| &nbsp;&nbsp; the managing board and executive committee charter as available on the website of the Dutch Company on the date of this letter, dated 29 January 2025<br>|
| &nbsp;&nbsp; "**NautaDutilh**"<br>| &nbsp;&nbsp; NautaDutilh N.V.<br>|
| &nbsp;&nbsp; "**the Netherlands**"<br>| &nbsp;&nbsp; the European territory of the Kingdom of the Netherlands and "**Dutch**" is in or from the Netherlands<br>|
| &nbsp;&nbsp;"**Ordinary Shares**" | &nbsp;&nbsp; ordinary shares in the Dutch Company's capital, with a nominal value of EUR 1.04 each<br>|
| &nbsp;&nbsp; "**Registration Statement**"<br>| &nbsp;&nbsp; the Dutch Company's registration statement on Form F-3 under the U.S. Securities Act of 1933, as amended, as filed by the Dutch Company with the SEC on 25 March 2026 and which will become effective on 25 March, 2026<br>|
| &nbsp;&nbsp;"**Relevant Moment**" | &nbsp;&nbsp; each time when Warrant Shares are issued pursuant to the exercise of the Warrant<br>|
| &nbsp;&nbsp;"**Resolutions**" | &nbsp;&nbsp; each of the following:<br> a. the minutes, convening notice and explanatory notes of the General Meeting held on 28 May 2025, in each case as available on the website of the Dutch Company on the date of this letter; and<br> b. the resolutions as set out in the Supervisory Board Certificate dated 25 March 2026 which, among other matters, include the issuing the Warrant, the right to subscribe for up to 24,755,584 Ordinary Shares and excluding pre-emption rights in connection therewith<br>|
| &nbsp;&nbsp; "**SEC**"<br>"**Supervisory Board Certificate**"<br>| &nbsp;&nbsp; the United States Securities and Exchange Commission<br>the supervisory board certificate recording the resolutions taken at the supervisory board meeting of 25 March 2026.<br>|

---

![](image_001.jpg)

---

| | |
|:---|:---|
| &nbsp;&nbsp; "**Supervisory Board Charter**"<br>| &nbsp;&nbsp; the supervisory board charter dated 30 December 2025, as available on the website of the Dutch Company on the date of this letter<br>|
| &nbsp;&nbsp;"**Warrant**" | &nbsp;&nbsp; the warrant to purchase Warrant Shares subject to the terms and conditions of the Warrant Agreement<br>|
| &nbsp;&nbsp;"**Warrant Agreement**" | &nbsp;&nbsp; the warrant entered into between the Dutch Company and the Warrant Holder, dated 6 February 2026<br>|
| &nbsp;&nbsp;"**Warrant Holder**" | &nbsp;&nbsp; Amazon.com NV Investment Holdings LLC<br>|
| &nbsp;&nbsp;"**Warrant Shares**" | &nbsp;&nbsp; 24,755,584 Ordinary Shares<br>|

---

![](image_001.jpg)

**EXHIBIT B**

**LIST OF CORPORATE DOCUMENTS**

1. the Deed of Incorporation;

2. the Deed of Conversion;

3. the Current Articles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. the Extract;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. the Managing Board and Executive Committee Charter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. the Supervisory Board Charter; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. the Supervisory Board Certificate.

## Exhibit 23.1

**Consent of Independent Registered Public Accounting Firm**

We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form F-3) and related Prospectus of STMicroelectronics N.V. for the registration of 24,755,584 shares of its common stock and to the incorporation by reference therein of our reports dated February 26, 2026, with respect to the consolidated financial statements and financial statement schedule on page S-1 of STMicroelectronics N.V., and the effectiveness of internal control over financial reporting of STMicroelectronics N.V., included in its Annual Report (Form 20-F) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.

/s/ Ernst & Young AG

Lancy - Geneva, Switzerland

March 25, 2026

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**F-3ASR**

**STMicroelectronics N.V.**

**Table 1: Newly Registered and Carry Forward Securities**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Line Item Type** | **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* |
| Fees to be Paid | Equity | Common Shares | (1) | Other | 24755584(2) | $31.95 | $790940908.80 | 0.0001381 | $109228.94 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $790940908.80 |  | 109228.94 |
| Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: |  |  |  |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $109228.94 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Estimated in accordance with Rules 457(c) and 457(o) solely for the purpose of calculating the amount of the registration fee on the basis of the average of the high and low prices for a share of the registrant's ordinary shares as reported on the New York Stock Exchange on March 24, 2026. (2) Represents ordinary shares of the registrant that may be offered for resale by the selling securityholder upon exercise of a warrant to purchase the registrant's ordinary shares. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the ordinary shares being registered hereunder include such indeterminate number of ordinary shares as may be issuable with respect to the ordinary shares being registered hereunder as a result of any stock dividend, stock split, recapitalization or similar transaction.